<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section - Smaill, FM - 2014 | Cochrane Library</title> <meta content="Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section - Smaill, FM - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007482.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section - Smaill, FM - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007482.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007482.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section" name="citation_title"/> <meta content="Fiona M Smaill" name="citation_author"/> <meta content="McMaster University" name="citation_author_institution"/> <meta content="smaill@mcmaster.ca" name="citation_author_email"/> <meta content="Rosalie M Grivell" name="citation_author"/> <meta content="The University of Adelaide, Women's and Children's Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD007482.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/10/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007482.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007482.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007482.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antibiotic Prophylaxis [*adverse effects]; Bacterial Infections [*prevention &amp; control]; Cesarean Section [*adverse effects]; Endometritis [*prevention &amp; control]; Postoperative Complications [*prevention &amp; control]; Randomized Controlled Trials as Topic; Surgical Wound Infection [prevention &amp; control]; Urinary Tract Infections [prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007482.pub3&amp;doi=10.1002/14651858.CD007482.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007482\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007482\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","hr","fr","de","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007482.pub3",title:"Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section",firstPublishedDate:"Oct 28, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007482.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007482.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007482.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007482.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007482.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007482.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007482.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007482.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007482.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007482.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13953 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007482.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0109"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0029"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0030"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0071"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-sec-0102"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/table_n/CD007482StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/table_n/CD007482StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information#CD007482-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Fiona M Smaill</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information#CD007482-cr-0003">Rosalie M Grivell</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information/en#CD007482-sec-0122">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 October 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007482.pub3">https://doi.org/10.1002/14651858.CD007482.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007482-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007482-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007482-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007482-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007482-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007482-abs-0001" lang="en"> <section id="CD007482-sec-0001"> <h3 class="title" id="CD007482-sec-0001">Background</h3> <p>The single most important risk factor for postpartum maternal infection is cesarean section. Although guidelines endorse the use of prophylactic antibiotics for women undergoing cesarean section, there is not uniform implementation of this recommendation. This is an update of a Cochrane review first published in 1995 and last updated in 2010. </p> </section> <section id="CD007482-sec-0002"> <h3 class="title" id="CD007482-sec-0002">Objectives</h3> <p>To assess the effects of prophylactic antibiotics compared with no prophylactic antibiotics on infectious complications in women undergoing cesarean section. </p> </section> <section id="CD007482-sec-0003"> <h3 class="title" id="CD007482-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 July 2014) and reference lists of retrieved papers. </p> </section> <section id="CD007482-sec-0004"> <h3 class="title" id="CD007482-sec-0004">Selection criteria</h3> <p>Randomized controlled trials (RCTs) and quasi‐RCTs comparing the effects of prophylactic antibiotics versus no treatment in women undergoing cesarean section. </p> </section> <section id="CD007482-sec-0005"> <h3 class="title" id="CD007482-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the studies for inclusion, assessed risk of bias and carried out data extraction. The clinically important primary outcomes were wound infection, endometritis, serious maternal infectious complications and adverse effects on the infant. We presented dichotomous data as risk ratios (RR), with 95% confidence intervals (CIs) and combined trials in meta‐analyses. We assessed the quality of evidence using the GRADE approach. </p> </section> <section id="CD007482-sec-0006"> <h3 class="title" id="CD007482-sec-0006">Main results</h3> <p>We identified 95 studies enrolling over 15,000 women. Compared with placebo or no treatment, the use of prophylactic antibiotics in women undergoing cesarean section reduced the incidence of wound infection (RR 0.40, 95% CI 0.35 to 0.46, 82 studies, 14,407 women), endometritis (RR 0.38, 95% CI 0.34 to 0.42, 83 studies, 13,548 women) and maternal serious infectious complications (RR 0.31, 95% CI 0.20 to 0.49, 32 studies, 6159 women). When only studies that included women undergoing an elective cesarean section were analyzed, there was also a reduction in the incidence of wound infections (RR 0.62, 95% CI 0.47 to 0.82, 17 studies, 3537 women) and endometritis (RR 0.38, 95% CI 0.24 to 0.61, 15 studies, 2502 women) with prophylactic antibiotics. Similar estimates of effect were seen whether the antibiotics were administered before the cord was clamped or after. The effect of different antibiotic regimens was studied and similar reductions in the incidence of infections were seen for most of the antibiotics and combinations. </p> <p>There were no data on which to estimate the effect of maternal administration of antibiotics on infant outcomes. No studies systematically collected and reported on adverse infant outcomes nor the effect of antibiotics on the developing infant immune system. No studies reported on the incidence of oral candidiasis (thrush) in babies. Maternal adverse effects were also rarely described. </p> <p>We judged the evidence for antibiotic treatment compared with no treatment to be of moderate quality; most studies lacked an adequate description of methods and were assessed as being at unclear risk of bias. </p> </section> <section id="CD007482-sec-0007"> <h3 class="title" id="CD007482-sec-0007">Authors' conclusions</h3> <p>The conclusions of this review support the recommendation that prophylactic antibiotics should be routinely administered to all women undergoing cesarean section to prevent infection. Compared with placebo or no treatment, the use of prophylactic antibiotics in women undergoing cesarean section reduced the incidence of wound infection, endometritis and serious infectious complications by 60% to 70%. There were few data on adverse effects and no information on the effect of antibiotics on the baby, making the assessment of overall benefits and harms difficult. Prophylactic antibiotics given to all women undergoing elective or non‐elective cesarean section is beneficial for women but there is uncertainty about the consequences for the baby. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007482-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007482-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007482-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007482-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007482-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007482-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007482-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007482-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007482-abs-0004">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007482-abs-0003" lang="en"> <h3>Routine antibiotics at cesarean section to reduce infection</h3> <p>Women undergoing cesarean section have a five to 20‐fold greater chance of getting an infection compared with women who give birth vaginally. These infections can be in the organs within the pelvis, around the surgical incision and sometimes the urine. The infections can be serious, and very occasionally can lead to the mother’s death. The potential benefits of reducing infection for the mother need to be balanced against any adverse effects such as nausea, vomiting, skin rash and rarely allergic reactions in the mother, and any effect of antibiotics on the baby, including thrush. This review looked at whether antibiotics are effective in preventing infection in women having a cesarean section. It also studied the effect of giving the antibiotics before or after the cord is clamped and different kinds of antibiotics. The review found 95 studies involving over 15,000 women. Routine use of antibiotics at cesarean section reduced the risk of wound and womb infections in mothers as well as the risk of serious complications of infections for the mothers by 60% to 70%. This was so whether the cesarean section was planned (elective) or not, and whether the antibiotics were given before or after clamping of the umbilical cord. The evidence to support antibiotic treatment was of moderate quality but often the way the study was done was not described well enough. None of the studies looked properly at possible adverse effects on the baby and so, although there are benefits for the mother, there is some uncertainty about whether there are any important effects on the baby. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007482-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007482-sec-0109"></div> <h3 class="title" id="CD007482-sec-0110">Implications for practice</h3> <section id="CD007482-sec-0110"> <p>The conclusions of this review support the recommendations in guidelines that prophylactic antibiotics should be routinely administered to all women undergoing cesarean section to prevent infection. No conclusions can be drawn from this review about the relative benefit and harms of administering antibiotics before or after clamping of the cord nor which antimicrobial regimen should be selected, although a first generation cephalosporin was shown to be effective. Obstetric units should collect data on infection rates following cesarean section and adherence to guidelines for appropriate prophylactic antibiotic administration as important quality indicators. </p> </section> <h3 class="title" id="CD007482-sec-0111">Implications for research</h3> <section id="CD007482-sec-0111"> <p>Further placebo‐controlled trials of the effectiveness of antibiotics with cesarean section are not ethically justified, but studies are needed to ascertain infant outcomes. Any future studies should use the list of outcomes identified here as a minimum data set and, in particular, include possible adverse effects on the infant and what role antimicrobial prophylaxis has on the development of antibiotic resistance. There should be research on methods to implement effective policies of prophylaxis for women undergoing cesarean section. Rates of infection following cesarean section are higher than for many other surgical procedures, even with a policy of uniform prophylaxis. Future research should look at interventions to reduce further the incidence of infection from that achieved with our current approach to antibiotic prophylaxis, e.g. the topical vaginal administration of metronidazole (<a href="./references#CD007482-bbs2-0110" title="PittC , Sanchez‐RamosL , KaunitzA . Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. Obstetrics &amp; Gynecology2001;98:745‐50. ">Pitt 2001</a>), the timing of antibiotic administration, whether there are advantages to an extended spectrum regimen (<a href="./references#CD007482-bbs2-0176" title="TitaATN , RouseDJ , BlackwellS , SaadeGR , SpongCY , AndrewsWW . Emerging concepts in antibiotic prophylaxis for cesarean delivery. Obstetrics &amp; Gynecology2009;113:675‐82. ">Tita 2009</a>) and determine the role of surgical technique, pre‐ and intra‐operative preparation and infection control policies on infection rates. Research into the perceptions of the advantages and disadvantages of the intervention from the perspective of the woman and the healthcare provider will help define educational and research needs. </p> <p>Without any data on adverse events, the benefits versus harms of the intervention cannot be assessed, nor a group of women identified in whom prophylactic antibiotics need not be administered because of a very low risk of infection. There is a theoretical opportunity for a cost‐effective analysis to be performed in a unit where routine prophylactic antibiotics are not administered to women undergoing an elective cesarean section and where the risk of infection is very low, in an attempt to identify women at increased risk of infection in whom prophylaxis may be cost‐effective. However, there is currently no evidence to support such a strategy. Because of local variation in practice and women, the results of such research will likely only be applicable to an individual unit and not generalizable. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007482-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007482-sec-0022"></div> <div class="table" id="CD007482-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics versus no antibiotics for preventing infection after cesarean section</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics versus no antibiotics for preventing infection after cesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> Women undergoing cesarean section.<br/> <b>Settings:</b> Both high‐ and low‐income countries.<br/> <b>Intervention:</b> Antibiotic prophylaxis<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antibiotic prophylaxis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Maternal wound infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low (elective)<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.40</b> <br/> (0.35 to 0.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>14407<br/> (82 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> <br/> (24 to 31) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Median<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>89 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> <br/> (31 to 41) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Other (includes emergency)<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b> <br/> (34 to 45) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Maternal endometritis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low (elective)<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.38</b> <br/> (0.34 to 0.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>13548<br/> (83 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (13 to 16) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Median<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>160 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> <br/> (54 to 67) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Other (includes emergency)<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>184 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> <br/> (63 to 77) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal serious infectious complications</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b><sup>4</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> <br/> (5 to 12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.31</b> <br/> (0.2 to 0.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6159<br/> (32 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects on infant</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infant outcomes were not systematically collected nor reported. <sup>6</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All classes of antibiotics, dosing regimens (both before and after clamping of the cord) and routes of administration were included.<br/> <sup>2</sup> The low risk baseline value is the mean of the control groups of studies reporting outcomes for elective cesarean sections; the other risk estimate is derived from the remaining studies in the review and includes emergency cesarean sections and studies which did not meet our criteria for elective.The median value from all studies is also reported.<br/> <sup>3</sup> In most studies the assessment of bias was judged as unclear. In a third of studies the control group did not receive a placebo and lack of blinding could have influenced the assessment of outcomes. In less than 20% of studies was there an adequate description of sequence generation.<br/> <sup>4</sup> The study population baseline risk is the mean value in the control groups from all studies that reported this outcome.<br/> <sup>5</sup> There was no consistent approach to the definition of serious infectious complications; in only 32 studies was this outcome reported.<br/> <sup>6</sup> No study reported effects of antibiotics on the infant immune system or outcome of oral thrush. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007482-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotics versus no antibiotics for preventing infection after elective cesarean section</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics versus no antibiotics for preventing infection after elective cesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> Women undergoing elective cesarean section<br/> <b>Settings:</b> Both high‐ and low‐income countries<br/> <b>Intervention:</b> Antibiotic prophylaxis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antibiotic prophylaxis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal wound infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (32 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.62</b> <br/> (0.47 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3537<br/> (17 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal endometritis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (9 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.38</b> <br/> (0.24 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2502<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal serious infectious complications</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.01</b> <br/> (0.04 to 24.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>545<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was only one adverse event reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects on infant</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infant outcomes were very infrequently reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The study population baseline risk is the mean value in the control groups from all studies that included women undergoing elective cesarean section.<br/> <sup>2</sup> In most studies the assessment of bias was judged as unclear.<br/> <sup>3</sup> There was only one serious infectious complication reported. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007482-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007482-sec-0023"></div> <p>The single most important risk factor for postpartum maternal infection is cesarean section (<a href="./references#CD007482-bbs2-0134" title="DeclercqE , BargerM , CabralHJ , EvansSR , KotelchuckM , SimonC , et al. Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births. Obstetrics &amp; Gynecology2007;109(3):669‐77. ">Declercq 2007</a>; <a href="./references#CD007482-bbs2-0141" title="GibbsRS . Clinical risk factors for puerperal infection. Obstetrics &amp; Gynecology1980;55(5 Suppl):178S‐184S. ">Gibbs 1980</a>). Women undergoing cesarean section have a five to 20‐fold greater risk for infection and infectious morbidity compared with a vaginal birth. In Western countries the percentage of live births by cesarean section is around 27% (range 14.7% to 49%) (<a href="./references#CD007482-bbs2-0164" title="Organization for Economic Co‐operation and Development (OECD). Health at a Glance 2013: OECD Indicators. http://dx.doi.org/10.1787/health_glance‐2013‐en. OECD Publishing. ">OECD 2013</a>); in developing countries the overall rate is around 12% but varies widely by region (0.40% to 40%) (<a href="./references#CD007482-bbs2-0175" title="ThomasJ . Rates of cesarean delivery in developing countries suggest unequal access. International Family Planning Perspectives2006;32(2):105. ">Thomas 2006</a>). Infectious complications that occur after cesarean births are an important and substantial cause of maternal morbidity and are associated with a significant increase in hospital stay (<a href="./references#CD007482-bbs2-0146" title="HendersonE , LoveEJ . Incidence of hospital‐acquired infections associated with caesarean section. Journal of Hospital Infection1995;29:245‐55. ">Henderson 1995</a>). Infections can affect the pelvic organs, the surgical wound, and the urinary tract. </p> <section id="CD007482-sec-0024"> <h3 class="title" id="CD007482-sec-0024">Description of the condition</h3> <p>Infectious complications following cesarean birth include fever (febrile morbidity), wound infection, endometritis (inflammation of the lining of the uterus), and urinary tract infection. There can also occasionally be serious infectious complications including pelvic abscess (collection of pus in the pelvis), bacteremia (bacterial infection in the blood), septic shock (reduced blood volume due to infection), necrotizing fasciitis (tissue destruction in the uterine wall) and septic pelvic vein thrombophlebitis (inflammation and infection of the veins in the pelvis); sometimes these can lead to maternal mortality (<a href="./references#CD007482-bbs2-0127" title="BoggessKA , WattsDH , HillierSL , KrohnMA , BenedettiTJ , EschenbachDA . Bacteremia shortly after placental separation during cesarean delivery. Obstetrics &amp; Gynecology1996;87:779‐84. ">Boggess 1996</a>; <a href="./references#CD007482-bbs2-0139" title="EnkinMW , EnkinE , ChalmersI , HemminkiE . Prophylactic antibiotics in association with caesarean section. In: ChalmersI , EnkinMW , KeirseMJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:1246‐69. ">Enkin 1989</a>; <a href="./references#CD007482-bbs2-0141" title="GibbsRS . Clinical risk factors for puerperal infection. Obstetrics &amp; Gynecology1980;55(5 Suppl):178S‐184S. ">Gibbs 1980</a>; <a href="./references#CD007482-bbs2-0154" title="LeighDA , EmmanuelFX , SedgwickJ , DeanR . Post‐operative urinary tract infection and wound infection in women undergoing caesarean section: a comparison of two study periods in 1985 and 1987. Journal of Hospital Infection1990;15:107‐16. ">Leigh 1990</a>). </p> <p>Fever can occur after any operative procedure, and a low grade fever following a cesarean birth may not necessarily be a marker of infection (<a href="./references#CD007482-bbs2-0155" title="MacLeanAB . Puerperal pyrexia. In: MacLeanAB editor(s). Clinical Infection in Obstetrics and Gynecology. Oxford: Blackwell Scientific Publications, 1990:195‐209. ">MacLean 1990</a>). Without prophylaxis, the incidence of endometritis is about 20% and rates of wound infection and serious infectious complications as high as 25% have been reported (<a href="./references#CD007482-bbs2-0139" title="EnkinMW , EnkinE , ChalmersI , HemminkiE . Prophylactic antibiotics in association with caesarean section. In: ChalmersI , EnkinMW , KeirseMJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:1246‐69. ">Enkin 1989</a>). There has been no consistent application of a standard definition for endometritis nor wound infection, and surveillance strategies to confirm infection, especially following hospital discharge, vary widely (<a href="./references#CD007482-bbs2-0124" title="BakerC , LuceJ , ChenowethC , FriedmanC . Comparison of case‐finding methodologies for endometritis after cesarean section. American Journal of Infection Control1995;23:27‐33. ">Baker 1995</a>; <a href="./references#CD007482-bbs2-0150" title="HultonLJ , OlmstedRN , Treston‐AurandJ , CraigCP . Effect of postdischarge surveillance on rates of infectious complications after cesarean section. American Journal of Infection Control1992;20:198‐201. ">Hulton 1992</a>). Differences in ethnicity and socioeconomic status of the population studied will explain some of the variability in incidence, as will the use of different criteria to diagnose infection (<a href="./references#CD007482-bbs2-0147" title="HerbertPR , ReedG , EntmanSS , MitchelEF , BergC , GriffinM . Serious maternal morbidity after childbirth: prolonged hospital stays and readmissions. Obstetrics &amp; Gynecology1999;94(6):942‐7. ">Herbert 1999</a>). Using the Centers for Disease Control (CDC) definitions for infection, the pooled mean rate of surgical site infections after cesarean section for US hospitals participating in the CDC and Prevention's National Nosocomial Infections Surveillance System (NNIS) from January 1992 through June 2004 was 3.15%, ranging from 2.71% for low‐risk patients to 7.53% for high‐risk patients (<a href="./references#CD007482-bbs2-0163" title="A report from the NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control2004;32(8):470‐85. ">NNIS 2004</a>). These rates, when compared with infection rates following other surgical procedures that are collected as part of the NNIS system, are high. Given the number of cesarean sections performed, these rates translate into very large numbers of women with an infectious complication following birth, and significant costs and morbidity. </p> <p>Factors that have been associated with an increased risk of infection and infectious morbidity among women who have a cesarean include emergency cesarean section, labor and its duration, ruptured membranes and the duration of rupture, the socioeconomic status of the woman, number of prenatal visits, vaginal examinations during labor, internal fetal monitoring, urinary tract infection, anemia, blood loss, obesity, diabetes, general anesthesia, development of subcutaneous hematoma, the skill of the operator and the operative technique (<a href="./references#CD007482-bbs2-0125" title="BeattiePG , RingsTR , HunterMF , LakeY . Risk factors for wound infection following caesarean section. Australian and New Zealand Journal of Obstetrics and Gynaecology1994;34:398‐402. ">Beattie 1994</a>; <a href="./references#CD007482-bbs2-0135" title="DesjardinsC , DialloHO , Audet‐LapointeP , HarelF . Retrospective study of post‐cesarean endometritis. 1992‐1993. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1996;25:419‐23. ">Desjardins 1996</a>; <a href="./references#CD007482-bbs2-0139" title="EnkinMW , EnkinE , ChalmersI , HemminkiE . Prophylactic antibiotics in association with caesarean section. In: ChalmersI , EnkinMW , KeirseMJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:1246‐69. ">Enkin 1989</a>; <a href="./references#CD007482-bbs2-0141" title="GibbsRS . Clinical risk factors for puerperal infection. Obstetrics &amp; Gynecology1980;55(5 Suppl):178S‐184S. ">Gibbs 1980</a>; <a href="./references#CD007482-bbs2-0153" title="KillianCA , GraffunderEM , VinciguerraTJ , VeneziaRA . Risk factors for surgical‐site infections following cesarean section. Infection Control and Hospital Epidemiology2001;22:613‐7. ">Killian 2001</a>; <a href="./references#CD007482-bbs2-0156" title="MagannEF , WashburneJF , HarrisRL , BassJD , DuffWP , MorrisonJC . Infectious morbidity, operative blood loss, and length of the operative procedure after cesarean delivery by method of placental removal and site of uterine repair. Journal of the American College of Surgeons1995;181:517‐20. ">Magann 1995</a>; <a href="./references#CD007482-bbs2-0165" title="OlsenMA , ButlerAM , WillerDM , DevkotaP , GrossGA , FraserVJ . Risk factors for surgical site infection after low transverse cesarean section. Infection Control and Hospital Epidemiology2008;29:477‐84. ">Olsen 2008</a>; <a href="./references#CD007482-bbs2-0181" title="WebsterJ . Post‐caesarean wound infection: a review of the risk factors. Australian and New Zealand Journal of Obstetrics and Gynaecology1988;28:210‐7. ">Webster 1988</a>). The association of bacterial vaginosis with an increased incidence of endometritis following cesarean birth has also been reported (<a href="./references#CD007482-bbs2-0177" title="WattsDH , KrohnMA , HillierSL , EschenbachDA . Bacterial vaginosis as a risk factor for post‐cesarean endometritis. Obstetrics &amp; Gynecology1990;75:52‐8. ">Watts 1990</a>). </p> <p>The most important source of micro‐organisms responsible for post‐cesarean section infection is the genital tract, particularly if the membranes are ruptured. Even in the presence of intact membranes, microbial invasion of the intrauterine cavity is common, especially with preterm labor (<a href="./references#CD007482-bbs2-0179" title="WattsDH , KrohnMA , HillierSL , EschenbachDA . The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstetrics &amp; Gynecology1992;79:351‐7. ">Watts 1992</a>). Infections are commonly polymicrobial (caused by many organisms). Pathogens isolated from infected wounds and the endometrium include <i>Escherichia coli</i> and other aerobic gram negative rods, group B streptococcus and other streptococcus species, <i>Enterococcus faecalis</i> , <i>Staphylococcus aureus</i> and coagulase negative staphylococci, anaerobes (including <i>Peptostreptococcus</i> species and <i>Bacteroides</i> species), <i>Gardnerella vaginalis</i> and genital mycoplasmas (<a href="./references#CD007482-bbs2-0158" title="MartensMG , KolrudBL , FaroS , MaccatoM , HammillH . Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases. Journal of Reproductive Medicine1995;40:171‐5. ">Martens 1995</a>; <a href="./references#CD007482-bbs2-0169" title="RobertsS , MaccatoM , FaroS , PinellP . The microbiology of post‐cesarean wound morbidity. Obstetrics &amp; Gynecology1993;81:383‐6. ">Roberts 1993</a>; <a href="./references#CD007482-bbs2-0178" title="WattsDH , HillierSL , EschenbachDA . Upper genital tract isolates at delivery as predictors of post‐cesarean infection among women receiving antibiotic prophylaxis. Obstetrics &amp; Gynecology1991;77:287‐92. ">Watts 1991</a>). Although <i>Ureaplasma urealyticum</i> is very commonly isolated from the upper genital tract and infected wounds, it is unclear whether it is a pathogen in this setting (<a href="./references#CD007482-bbs2-0169" title="RobertsS , MaccatoM , FaroS , PinellP . The microbiology of post‐cesarean wound morbidity. Obstetrics &amp; Gynecology1993;81:383‐6. ">Roberts 1993</a>). Wound infections caused by <i>Staphylococcus aureus</i> and coagulase negative staphylococci arise from contamination of the wound with the endogenous flora of the skin at the time of surgery (<a href="./references#CD007482-bbs2-0138" title="EmmonsSL , KrohnM , JacksonM , EschenbachDA . Development of wound infections among women undergoing cesarean section. Obstetrics &amp; Gynecology1988;72:559‐64. ">Emmons 1988</a>). </p> </section> <section id="CD007482-sec-0025"> <h3 class="title" id="CD007482-sec-0025">Description of the intervention</h3> <p>Guidelines recommend the use of antibiotics for prophylaxis for cesarean section, with the choice of antibiotic based on factors such as cost, half life, safety, antimicrobial resistance and spectrum of activity (<a href="./references#CD007482-bbs2-0121" title="American College of Obstetricians and Gynecologists. ACOG practice bulletin number 120, Prophylactic antibiotics in labor and delivery. Obstetrics &amp; Gynecology2011;117(6):1472‐83. ">ACOG 2011</a>; <a href="./references#CD007482-bbs2-0128" title="BratzlerDW , HouckPM . Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Clinical Infectious Diseases2004;38(12):1706‐15. ">Bratzler 2004</a>; <a href="./references#CD007482-bbs2-0162" title="National Institute for Health and Clinical Excellence. Caesarean Section. NICE Clinical Guideline 132. NICE, 2011. ">NICE 2011</a>; <a href="./references#CD007482-bbs2-0172" title="vanSchalkwykJ , VanEykN , for the Society of Obstetricians and Gynaecologists of Canada Infectious Diseases Committee. Antibiotic prophylaxis in obstetric procedures. Journal of Obstetrics and Gynaecology of Canada: JOGC2010;32(9):879‐85. ">SOGC 2010</a>). There are over 20 antibiotic regimens that have been compared for cesarean section prophylaxis. Some of these drugs have activity against a narrow range of potential pathogens (e.g. metronidazole, gentamicin), others specifically have additional anaerobic activity (e.g. cefoxitin and cefotetan), others have activity against <i>Staphylococcus aureus</i> (e.g. cefazolin) and yet others have an extended spectrum of coverage (e.g. meropenem). Details of the different antibiotic regimens for prophylaxis at cesarean section that have been compared and their effectiveness are included in another Cochrane review (<a href="./references#CD007482-bbs2-0122" title="AlfirevicZ , GyteGM , DouL . Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD008726] ">Alfirevic 2010</a>) </p> <p>There are differences in the route of administration of prophylactic antibiotics; for cesarean section the antibiotic is generally given intravenously. Usually a single dose is administered at the time of the procedure or multiple doses administered over a short period of time. </p> <p>For cesarean section, prophylactic antibiotics are administered either before or after the cord is clamped (<a href="./references#CD007482-bbs2-0130" title="ClassenDC , EvansRS , PestotnikSL , HornSD , MenloveRL , BurkeJP . The timing of prophylactic administration of antibiotics and the risk of surgical‐wound infection. New England Journal of Medicine1992;326(5):281‐6. ">Classen 1992</a>; <a href="./references#CD007482-bbs2-0132" title="CunninghamFG , LevenoKJ , DePalmaRT , RoarkM , RosenfeldCR . Perioperative antimicrobials for cesarean delivery: before or after cord clamping. Obstetrics &amp; Gynecology1983;62(2):151‐4. ">Cunningham 1983</a>; <a href="./references#CD007482-bbs2-0180" title="WaxJR , HerseyK , PhilputC , WrightMS , NicholsKV , EgglestonMK , et al. Single dose cefazolin prophylaxis for postcesarean infections: before vs after cord clamping. Journal of Maternal Fetal Medicine1997;6(1):61‐5. ">Wax 1997</a>), although general guidelines for the prevention of surgical site infections now recommend the antimicrobial dose is administered before the incision to achieve low infection rates (<a href="./references#CD007482-bbs2-0128" title="BratzlerDW , HouckPM . Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Clinical Infectious Diseases2004;38(12):1706‐15. ">Bratzler 2004</a>). Recent meta‐analyses on the timing of perioperative antibiotics for cesarean delivery have concluded that there was strong evidence that antibiotic prophylaxis that is given before skin incision decreases maternal infectious complications compared with intraoperative administration (<a href="./references#CD007482-bbs2-0123" title="BaaqeelH , BaaqeelR . Timing of administration of prophylactic antibiotics for caesarean section: a systematic review and meta‐analysis. BJOG: an international journal of obstetrics and gynaecology2013;120(6):661‐9. [DOI: 10.1111/1471‐0528.12036] ">Baaqeel 2013</a>; <a href="./references#CD007482-bbs2-0131" title="CostantineMM , RahmanM , GhulmiyahL , ByersBD , LongoM , WenT , et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. American Journal of Obstetrics and Gynecology2008;199(3):301.e1‐6. ">Costantine 2008</a>). However, it is argued that the timing of antibiotic administration may mask septic complications in the infant (<a href="./references#CD007482-bbs2-0132" title="CunninghamFG , LevenoKJ , DePalmaRT , RoarkM , RosenfeldCR . Perioperative antimicrobials for cesarean delivery: before or after cord clamping. Obstetrics &amp; Gynecology1983;62(2):151‐4. ">Cunningham 1983</a>). Additionally, if the antibiotic is given before cord clamping, the baby will be exposed to the antibiotic via the placenta, and there may be exposure through breast milk if the antibiotic is given either before or after cord clamping, though the passage of antibiotic through the breast milk is thought to minimal (<a href="./references#CD007482-bbs2-0139" title="EnkinMW , EnkinE , ChalmersI , HemminkiE . Prophylactic antibiotics in association with caesarean section. In: ChalmersI , EnkinMW , KeirseMJNC editor(s). Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press, 1989:1246‐69. ">Enkin 1989</a>). Because of the potential for adverse outcomes for the baby and the effect on maternal infectious complications, this review investigated the timing of antibiotic administration (<i>see</i><a href="#CD007482-sec-0034">Types of interventions</a>). </p> </section> <section id="CD007482-sec-0026"> <h3 class="title" id="CD007482-sec-0026">How the intervention might work</h3> <p>General principles for the prevention of any surgical infection include sound surgical technique, skin antisepsis and antimicrobial prophylaxis (<a href="./references#CD007482-bbs2-0166" title="OwenJ , AndrewsWW . Wound complications after cesarean sections. Clinical Obstetrics and Gynecology1994;37:842‐55. ">Owen 1994</a>). Antibiotics administered prophylactically reduce the bacterial inoculum at the time of surgery and decrease the rate of bacterial contamination of the surgical site. An adequate antibiotic level in the tissue can augment natural immune defence mechanisms and help kill bacteria that are invariably inoculated into the wound at the time of surgery (<a href="./references#CD007482-bbs2-0174" title="TalbotTR , KaiserAB . Postoperative infections and antimicrobial prophylaxis. In: MandellGL , BennettJE , DolinR editor(s). Principles and Practice of Infectious Diseases. 6th Edition. Philadelphia: Elsevier Inc, 2005:3533‐47. ">Talbot 2005</a>). </p> <section id="CD007482-sec-0027"> <h4 class="title">Potential adverse effects of antibiotic prophylaxis</h4> <p>There are commonly identified adverse effects of antibiotic therapy, which include gastrointestinal symptoms (nausea, vomiting or diarrhea), skin rashes, thrush (candidiasis, which can affect both mother and baby) and joint pain (<a href="./references#CD007482-bbs2-0133" title="DancerSJ . How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infectious Diseases2004;6:611‐9. ">Dancer 2004</a>). There can also occasionally be blood problems, kidney or liver damage (<a href="./references#CD007482-bbs2-0133" title="DancerSJ . How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infectious Diseases2004;6:611‐9. ">Dancer 2004</a>; <a href="./references#CD007482-bbs2-0184" title="WestphalJF , VetterD , BrogardJM . Hepatic side‐effects of antibiotics. Journal of Antimicrobial Chemotherapy1994;33:387‐401. ">Westphal 1994</a>) and anaphylaxis (a hypersensitivity reaction to a foreign substance leading to shock and collapse, which can be fatal). </p> <p>Because there are some data that antibiotics reaching the baby during labor, or in the very early postnatal period, can affect the pattern of bacterial flora in the infant gut, with the potential to affect the baby's developing immune system (<a href="./references#CD007482-bbs2-0126" title="Bedford RussellA , MurchS . Could peripartum antibiotics have delayed health consequences for the infant?. BJOG: an international journal of obstetrics and gynaecology2006;113:758‐65. ">Bedford Russell 2006</a>; <a href="./references#CD007482-bbs2-0183" title="WengM , WalkerWA . The role of gut microbiota in programming the immune phenotype. Journal of Developmental Origins of Health and Disease2013;4(3):203‐14. [DOI: 10.1017/S2040174412000712] ">Weng 2013</a>), it is important to assess the impact of antibiotics given to the mother on the baby's health. </p> <p>Antibiotic prophylaxis may lead to increased drug resistant strains of bacteria which may be associated with infection. Resistant organisms may spread within the hospital and be associated with hospital‐acquired drug resistant infections (<a href="./references#CD007482-bbs2-0133" title="DancerSJ . How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infectious Diseases2004;6:611‐9. ">Dancer 2004</a>). These adverse effects cannot be assessed readily in randomized controlled trials, and additional research needs to be undertaken to assess the impact of prophylactic antibiotic use on the level of resistant bacteria, e.g. MRSA and <i>C. difficile</i> in hospitals. </p> </section> </section> <section id="CD007482-sec-0028"> <h3 class="title" id="CD007482-sec-0028">Why it is important to do this review</h3> <p>Surveys suggest that there is inconsistent and variable application of the use of prophylactic antibiotics at cesarean sections (<a href="./references#CD007482-bbs2-0151" title="HuskinsWC , Ba‐ThikeK , FestinMR , LimpongsanurakS , LumbiganonP , PeedicayilA , et al. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. International Journal of Gynecology &amp; Obstetrics2001;73(2):141‐5. ">Huskins 2001</a>; <a href="./references#CD007482-bbs2-0159" title="MorisakiN , GanchimegT , OtaE , VogelJP , SouzaJP , MoriR , et al. Maternal and institutional characteristics associated with the administration of prophylactic antibiotics for caesarean section: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG: an international journal of obstetrics and gynaecology2014;121(Suppl 1):66‐75. [DOI: 10.1111/1471‐0528.12632] ">Morisaki 2014</a>; <a href="./references#CD007482-bbs2-0165" title="OlsenMA , ButlerAM , WillerDM , DevkotaP , GrossGA , FraserVJ . Risk factors for surgical site infection after low transverse cesarean section. Infection Control and Hospital Epidemiology2008;29:477‐84. ">Olsen 2008</a>; <a href="./references#CD007482-bbs2-0167" title="PedersenTK , BlaakaerJ . Antibiotic prophylaxis in cesarean section. Acta Obstetricia et Gynecologica Scandinavica1996;75:537‐9. ">Pedersen 1996</a>). Prophylactic antibiotics have been shown, in previous versions of this review, to be effective in reducing febrile morbidity, endometritis, wound infection and urinary tract infection (<a href="./references#CD007482-bbs2-0185" title="SmaillF . Prophylactic antibiotics for elective Caesarean section [revised 06 May 1993]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995. ">Smaill 1995a</a>; <a href="./references#CD007482-bbs2-0186" title="SmaillF . Prophylactic antibiotics in Caesarean section (all trials) [revised 03 August 1994]. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]. The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995. ">Smaill 1995b</a>; <a href="./references#CD007482-bbs2-0187" title="HofmeyrGJ , SmaillFM . Antibiotic prophylaxis for cesarean section. Cochrane Database of Systematic Reviews2002, Issue 3. [DOI: 10.1002/14651858.CD000933] ">Smaill 2002</a>; <a href="./references#CD007482-bbs2-0188" title="SmaillFM , GyteGML . Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD007482.pub2] ">Smaill 2010</a>). In addition, both ampicillin and first generation cephalosporins appeared to have similar efficacy in reducing post‐operative endometritis, and while there did not appear to be any added benefit in utilizing a more broad spectrum agent or a multiple dose regimen (<a href="./references#CD007482-bbs2-0122" title="AlfirevicZ , GyteGM , DouL . Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD008726] ">Alfirevic 2010</a>), other authors have questioned whether an extended spectrum agent should be recommended (<a href="./references#CD007482-bbs2-0176" title="TitaATN , RouseDJ , BlackwellS , SaadeGR , SpongCY , AndrewsWW . Emerging concepts in antibiotic prophylaxis for cesarean delivery. Obstetrics &amp; Gynecology2009;113:675‐82. ">Tita 2009</a>). It is important to update this evidence with more recent studies, to update the review methodology, to perform a subgroup analysis based on class of antibiotic and also to address the question of whether increasing antimicrobial resistance has had an impact on the benefit of antibiotic prophylaxis. </p> <p>The adverse effects of antibiotics for the woman and her infant and the potential for increased use of antimicrobial prophylaxis to contribute to the development of antimicrobial resistance are important considerations (<a href="./references#CD007482-bbs2-0066" title="MallaretMR , BlatierJF , RacinetC , FauconnierJ , FavierM , MicoudM . Economic benefit of using antibiotics prophylactically in cesarean sections with little risk of infection. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1990;19:1061‐4. RacinetC , MallaretMR , FavierM , BerthetJ , MorelI , FauconnierJ , et al. Antibiotic prophylaxis in cesarean sections without high risk of infection. Presse Medicale1990;19:1755‐8. ">Racinet 1990</a>; <a href="./references#CD007482-bbs2-0171" title="ShlaesDM , GerdingDN , JohnJJ , CraigWA , BornsteinDL , DuncanRA , et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance in hospitals. Clinical Infectious Diseases1997;25:584‐99. ">Shlaes 1997</a>), as are the cost‐effectiveness of different strategies (<a href="./references#CD007482-bbs2-0160" title="MugfordM , KingstonJ , ChalmersI . Reducing the incidence of infection after caesarean section: implications of prophylaxis for hospital resources. BMJ1989;299:1003‐6. ">Mugford 1989</a>). As well, it is important to assess any possible impact of maternal antibiotic treatment on the baby, as there is evidence that antibiotics given near or shortly after birth can affect the infant's gut bacterial flora, with the potential to impact mucosal and systemic immune function (<a href="./references#CD007482-bbs2-0126" title="Bedford RussellA , MurchS . Could peripartum antibiotics have delayed health consequences for the infant?. BJOG: an international journal of obstetrics and gynaecology2006;113:758‐65. ">Bedford Russell 2006</a>; <a href="./references#CD007482-bbs2-0183" title="WengM , WalkerWA . The role of gut microbiota in programming the immune phenotype. Journal of Developmental Origins of Health and Disease2013;4(3):203‐14. [DOI: 10.1017/S2040174412000712] ">Weng 2013</a>). </p> <p>Particularly controversial is whether antibiotic treatment should be given to all mothers or only to those at greatest risk of infection (<a href="./references#CD007482-bbs2-0137" title="EhrenkranzNJ , BlackwelderWC , PfaffSJ , PoppeD , YergDE , KaslowRA . Infections complicating low‐risk cesarean sections in community hospitals: efficacy of antimicrobial prophylaxis. American Journal of Obstetrics and Gynecology1990;162(2):337‐43. ">Ehrenkranz 1990</a>; <a href="./references#CD007482-bbs2-0142" title="GilstrapLC . Prophylactic antibiotics for cesarean section and surgical procedures. Journal of Reproductive Medicine1988;33:588‐90. ">Gilstrap 1988</a>; <a href="./references#CD007482-bbs2-0149" title="HowiePW , DaveyPG . Prophylactic antibiotics and caesarean section. BMJ1990;300:2‐3. ">Howey 1990</a>; <a href="./references#CD007482-bbs2-0173" title="SuonioS , SaarikoskiS , VohlonenI , KauhanenO . Risk factors for fever, endometritis and wound infection after abdominal delivery. International Journal of Gynecology and Obstetrics1989;29:135‐42. ">Suonio 1989</a>). Women undergoing cesarean section can be divided into low‐ and high‐risk groups for infection, with women undergoing an elective (planned or primary) procedure at lowest risk (<a href="./references#CD007482-bbs2-0121" title="American College of Obstetricians and Gynecologists. ACOG practice bulletin number 120, Prophylactic antibiotics in labor and delivery. Obstetrics &amp; Gynecology2011;117(6):1472‐83. ">ACOG 2011</a>). Women at high risk include those undergoing cesarean section after rupture of the membranes or onset of labor (<a href="./references#CD007482-bbs2-0121" title="American College of Obstetricians and Gynecologists. ACOG practice bulletin number 120, Prophylactic antibiotics in labor and delivery. Obstetrics &amp; Gynecology2011;117(6):1472‐83. ">ACOG 2011</a>). It has been suggested that institutions with a low levels of baseline infections may see no impact of routine use of antibiotics, while institutions with high baseline infection rates may see a benefit. We were interested to see if there was a difference in effectiveness depending on whether the women were at low or high risk of infection and performed a subgroup analysis based on whether the cesarean section was a planned procedure (elective) or whether there was active labor or ruptured membranes (non‐elective). </p> <p>This review will focus on whether antibiotics do more good than harm overall. Additional ways for trying to reduce post‐cesarean infections include: skin preparation at cesarean section (<a href="./references#CD007482-bbs2-0145" title="HadiatiD , HakimiM , NurdiatiD . Skin preparation for preventing infection following caesarean section. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007462.pub2] ">Hadiati 2012</a>); surgical technique (<a href="./references#CD007482-bbs2-0136" title="DoddJ , AndersonE , GatesS , GrivellR . Surgical techniques for uterine incision and uterine closure at the time of caesarean section. Cochrane Database of Systematic Reviews2014, Issue 7. [DOI: 10.1002/14651858.CD004732.pub3] ">Dodd 2014</a>), double gloving or changing gloves (or both) before closure; peritoneal lavage; and vaginal antiseptic solution preparation (<a href="./references#CD007482-bbs2-0144" title="HaasD , MorganS , ContrerasK . Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD007892.pub3] ">Haas 2013</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007482-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007482-sec-0029"></div> <p>To determine, from the best evidence available, the effectiveness of prophylactic antibiotics compared with placebo, or no treatment, given to women when undergoing a cesarean section for reducing the incidence of febrile morbidity, wound infection, endometritis, urinary tract infection or any serious infectious complication, and to assess potential maternal adverse effects and any impact on the infant, either short term or long term. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007482-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007482-sec-0030"></div> <section id="CD007482-sec-0031"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007482-sec-0032"> <h4 class="title">Types of studies</h4> <p>All randomized controlled trials (RCTs) to evaluate the effects of prophylactic antibiotics in women undergoing cesarean section were included. Quasi‐RCTs were also included. We planned to include cluster‐RCTs should any be identified but cross‐over trials are inappropriate for this question. </p> </section> <section id="CD007482-sec-0033"> <h4 class="title">Types of participants</h4> <p>Women undergoing cesarean section, both elective (planned) and non‐elective/emergency.</p> </section> <section id="CD007482-sec-0034"> <h4 class="title">Types of interventions</h4> <p>Trials were considered if they compared any prophylactic antibiotic regimen administered for cesarean section with placebo or no treatment. </p> </section> <section id="CD007482-sec-0035"> <h4 class="title">Types of outcome measures</h4> <section id="CD007482-sec-0036"> <h5 class="title">Primary outcomes</h5> <section id="CD007482-sec-0037"> <h6 class="title">Maternal</h6> <p> <ol id="CD007482-list-0001"> <li> <p>Febrile morbidity (fever)</p> </li> <li> <p>Wound infection (infection of the surgical incision)</p> </li> <li> <p>Endometritis (inflammation of the lining of the womb)</p> </li> <li> <p>Serious infectious complication (such as bacteremia, septic shock, septic thrombophlebitis, necrotizing fasciitis, or death attributed to infection) </p> </li> </ol> </p> </section> <section id="CD007482-sec-0038"> <h6 class="title">Infant</h6> <p> <ol id="CD007482-list-0002"> <li> <p>Immediate adverse effects of antibiotics on the infant (unsettled, diarrhea, rashes)</p> </li> <li> <p>Oral thrush (candidiasis)</p> </li> </ol> </p> </section> </section> <section id="CD007482-sec-0039"> <h5 class="title">Secondary outcomes</h5> <section id="CD007482-sec-0040"> <h6 class="title">Maternal</h6> <p> <ol id="CD007482-list-0003"> <li> <p>Urinary tract infection</p> </li> <li> <p>Adverse effects of treatment on the woman (e.g. allergic reactions, nausea, vomiting, diarrhea, skin rashes, yeast infections) </p> </li> <li> <p>Length of stay in hospital</p> </li> </ol> </p> </section> <section id="CD007482-sec-0041"> <h6 class="title">Infant</h6> <p> <ol id="CD007482-list-0004"> <li> <p>Length of stay in hospital</p> </li> <li> <p>Long‐term adverse effects (e.g. general health; frequency of visits to hospital)</p> </li> <li> <p>Immune system development (using a validated scoring assessment)</p> </li> </ol> </p> </section> <section id="CD007482-sec-0042"> <h6 class="title">Additional outcomes</h6> <p> <ol id="CD007482-list-0005"> <li> <p>Development of bacterial resistance</p> </li> <li> <p>Cost</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD007482-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD007482-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We contacted the Trials Search Co‐ordinator to search the Cochrane Pregnancy and Childbirth Group’s Trials Register (31 July 2014).  </p> <p>The Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by the Trials Search Co‐ordinator and contains trials identified from: </p> <p> <ol id="CD007482-list-0006"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE;</p> </li> <li> <p>weekly searches of Embase;</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the ‘Specialized Register’ section within the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a>. </p> <p>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co‐ordinator searches the register for each review using the topic list rather than keywords. </p> </section> <section id="CD007482-sec-0045"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists at the end of papers for further studies.</p> <p>We did not apply any language restrictions.</p> </section> </section> <section id="CD007482-sec-0046"> <h3 class="title" id="CD007482-sec-0046">Data collection and analysis</h3> <p>For methods used in the previous update, please see <a href="./references#CD007482-bbs2-0188" title="SmaillFM , GyteGML . Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD007482.pub2] ">Smaill 2010</a>. </p> <p>For this update (2014), the following methods, based on a standard template used by the Cochrane Pregnancy and Childbirth Group, were used. </p> <section id="CD007482-sec-0047"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion. </p> </section> <section id="CD007482-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion. Data were entered into Review Manager software (<a href="./references#CD007482-bbs2-0168" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. Where participants were randomized to more than two treatment groups either the intervention groups were combined to create a single pair‐wise comparison or the no treatment group was divided approximately evenly into two or more groups and independent comparisons made between intervention and no treatment groups (see details in <a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a>). </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD007482-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716%26format=REVMAN_GRAPHS#REF-Higgins-2011" target="_blank">Higgins 2011</a>). Any disagreement was resolved by discussion. </p> <section id="CD007482-sec-0050"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We have assessed the method as:</p> <p> <ul id="CD007482-list-0007"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007482-sec-0051"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We have assessed the methods as:</p> <p> <ul id="CD007482-list-0008"> <li> <p>low risk of bias (e.g. telephone or central randomization; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007482-sec-0052"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes, but an overall estimate of performance bias was reported. </p> <p>We have assessed the methods as:</p> <p> <ul id="CD007482-list-0009"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD007482-sec-0053"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes but an overall estimate of detection bias was reported. </p> <p>We have assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD007482-list-0010"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007482-sec-0054"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> </section> <section id="CD007482-sec-0055"> <h5 class="title">We have assessed methods as:</h5> <p> <ul id="CD007482-list-0011"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as‐treated’ analysis done with substantial departure of intervention received from that assigned at randomization); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007482-sec-0056"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD007482-list-0012"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD007482-sec-0057"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We planned to describe for each included study any important concerns we had about other possible sources of bias. </p> <p>For this update the quality of the evidence was assessed using the GRADE approach (<a href="./references#CD007482-bbs2-0170" title="SchunemannHJ . GRADE: from grading the evidence to developing recommendations. A description of the system and a proposal regarding the transferability of the results of clinical research to clinical practice [GRADE: Von der Evidenz zur Empfehlung. Beschreibung des Systems und Losungsbeitrag zur Ubertragbarkeit von Studienergebnissen]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen2009;103(6):391‐400. ">Schunemann 2009</a>) in order to assess the quality of the body of evidence relating to the following key outcomes for the main comparison of all cesarean sections and the subgroup of elective cesarean sections: </p> <p> <ol id="CD007482-list-0013"> <li> <p>Wound infection</p> </li> <li> <p>Endometritis</p> </li> <li> <p>Serious infectious complications</p> </li> <li> <p>Infant outcomes</p> </li> </ol> </p> <p>GRADE profiler (<a href="./references#CD007482-bbs2-0143" title="JanBrozek , AndrewOxman , HolgerSchünemann . GRADEpro. Version 3.6. The Cochrane Collaboration, 2008. ">GRADE 2008</a>) was used to import data from Review Manager 5.3 (<a href="./references#CD007482-bbs2-0168" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create ’Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD007482-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <section id="CD007482-sec-0059"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD007482-sec-0060"> <h5 class="title">Continuous data</h5> <p>We used the mean difference if outcomes were measured in the same way between trials. We planned to use the standardized mean difference to combine trials that measured the same outcome, but used different methods. </p> </section> </section> <section id="CD007482-sec-0061"> <h4 class="title">Unit of analysis issues</h4> <section id="CD007482-sec-0062"> <h5 class="title">Cluster‐randomized trials</h5> <p>We did not identify any cluster‐randomized trials, but we would include cluster‐randomized trials along with individually‐randomized trials in the analysis if we identify any in future updates to this review. We would adjust their sample size using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we used ICCs from other sources, we would report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If, in future updates, we identify cluster‐randomized trials, we plan to synthesize the relevant information. We would consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomization unit is considered to be unlikely. We would also acknowledge heterogeneity in the randomization unit and perform a sensitivity analysis to investigate the effects of the randomization unit. </p> </section> <section id="CD007482-sec-0063"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials are inappropriate for this question.</p> </section> </section> <section id="CD007482-sec-0064"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, levels of attrition were noted. In a subsequent update of this review, we will include a sensitivity analysis, with poor quality studies with high levels of missing data excluded from the analysis. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomized to each group in the analyses. The denominator for each outcome in each trial was the number randomized minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD007482-sec-0065"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the I² and Tau² or Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD007482-sec-0066"> <h4 class="title">Assessment of reporting biases</h4> <p>We investigated reporting biases (such as publication bias) using funnel plots for the main analyses of the primary outcomes. In future updates, if asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD007482-sec-0067"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD007482-bbs2-0168" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect, i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>We planned that if there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we would use random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary would be treated as the average range of possible treatment effects and the clinical implications of treatment effects differing between trials would be discussed. If the average treatment effect was not clinically meaningful, we would not combine trials. Where we used random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD007482-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We carried out the following subgroup analyses to address specific questions about particular patient groups and types of interventions. </p> <p> <ol id="CD007482-list-0014"> <li> <p>By antibiotic regimen (see <a href="#CD007482-tbl-0003">Table 1</a> for classification based on class of antibiotic, spectrum of activity and drug combinations). </p> </li> <li> <p>By type of surgery: (a) elective cesarean section; (b) non‐elective cesarean section; and (c) mixed or not defined. (Rupture of membranes for more than six hours or the presence of labor was used to differentiate a non‐elective cesarean section from an elective procedure.) </p> </li> <li> <p>By time of administration: (a) before cord clamping; (b) after cord clamping; (c) not defined. </p> </li> </ol> </p> <div class="table" id="CD007482-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Classification of antibiotics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penicillinase‐resistant penicillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cloxacillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Extended spectrum of activity compared with natural penicillin</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aminopenicillins</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ampicillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extended‐spectrum penicillins</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ticarcillin, pipericillin, carbenicillin, mezlocillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Beta‐lactamase inhibitor combination</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sulbactam</p> <p>Augmentin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cephalosporins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1st generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cefazolin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2nd generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cefamandole, cefuroxime</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cefamycins (2nd generation)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cefoxitin, cefotetan</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3rd generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4th generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Carbapenems and monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tetracyclines</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Macrolides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aminoglycosides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gentamicin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clindamycin, lincomycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nitroimidazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Metronidazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aminoglycoside containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> <p>The following outcomes were used in subgroup analysis.</p> <p><b>Maternal</b> </p> <p> <ol id="CD007482-list-0015"> <li> <p>Febrile morbidity (fever)</p> </li> <li> <p>Wound infection (infection of the surgical incision)</p> </li> <li> <p>Endometritis (inflammation of the lining of the womb)</p> </li> <li> <p>Serious infectious complication (such as bacteremia, septic shock, septic thrombophlebitis, necrotizing fasciitis, or death attributed to infection) </p> </li> <li> <p>Urinary tract infection</p> </li> </ol> </p> <section id="CD007482-sec-0069"> <h5 class="title">Infant</h5> <p> <ol id="CD007482-list-0016"> <li> <p>Immediate adverse effects of antibiotics on the infant (unsettled, diarrhea, rashes)</p> </li> <li> <p>Oral thrush (candidiasis)</p> </li> </ol> </p> <p>If we had identified substantial heterogeneity, we would have investigated it using the subgroup analyses. We would have considered whether an overall summary was meaningful, and if it was, used random‐effects analysis to produce it. We did assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD007482-bbs2-0168" title="The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2014. ">RevMan 2014</a>). The results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value have been calculated. </p> </section> </section> <section id="CD007482-sec-0070"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a sensitivity analysis to explore the effect of trial quality assessed by concealment of allocation (quasi‐randomized trials), with these poor quality studies being excluded from the analyses, in order to assess whether this made any difference to the overall result. We plan to explore in a subsequent update to this review the effect of other sources of bias on the estimate of outcomes by performing additional sensitivity analyses, e.g. examine the effects of only including studies where there was a low risk of allocation bias and selection bias (i.e. effective blinding of participants and personnel). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007482-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007482-sec-0071"></div> <section id="CD007482-sec-0072"> <h3 class="title">Description of studies</h3> <section id="CD007482-sec-0073"> <h4 class="title">Results of the search</h4> <p>The search of the Cochrane Pregnancy and Childbirth Group’s Trials Register identified 134 reports of 120 studies. Ninety‐five studies were included (<a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a>), 25 were excluded (<a href="./references#CD007482-sec-0129" title="">Characteristics of excluded studies</a>). We found no additional studies through searching reference lists. </p> </section> <section id="CD007482-sec-0074"> <h4 class="title">Included studies</h4> <p>The 95 studies that met the inclusion criteria for this review enrolled over 15,000 women. For detailed information on the studies, <i>see</i> table of <a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a>. No study reported on baseline risk of infection before the intervention. Most studies adequately described the characteristics of the women who were enrolled, including details of the indication for cesarean section, mean duration of labor and membrane rupture and number of repeat sections. Several studies included a majority of women who were identified as from a low socioeconomic group, but other studies enrolled women who were not perceived to be at an increased risk of infection because of socioeconomic status. One study included information on the number of women who were HIV positive (<a href="./references#CD007482-bbs2-0005" title="BagrateeJ , MoodleyJ , KleinschmidtI , ZawilskiW . A randomized controlled trial of antibiotic prophylaxis in elective caesarean section. BJOG: an international journal of obstetrics and gynaecology2001;108:143‐8. BagrateeJS , MoodleyJ . Antibiotic prophylaxis in elective caesarean section. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 Oct 3‐6; Cape Town South Africa. 1999:6. ">Bagratee 2001</a>). In no study were details on the incidence of bacterial vaginosis provided. One more recent study reported that there were no methicillin‐resistant <i>Staphylococcus aureus</i> infections in the study population (<a href="./references#CD007482-bbs2-0090" title="WittA , DonerM , PetricevicL , BergerA , GermannP , HeinzeG , et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double‐blind, prospective, randomized, placebo‐controlled trial. Archives of Surgery2011;146(12):1404‐9. [PUBMED: 22184305] ">Witt 2011</a>). </p> <section id="CD007482-sec-0075"> <h5 class="title">Setting</h5> <p>While the majority of the studies included in the review were conducted in developed countries (e.g. US, Western Europe, Scandinavia, Canada and New Zealand), studies were reported from developing countries including Sudan, Nigeria, Tunisia, Kenya, Zimbabwe, and South Africa as well as Mexico, Greece, Turkey, Israel, the Middle East, China and Malaysia. </p> </section> <section id="CD007482-sec-0076"> <h5 class="title">Type of cesarean section</h5> <p>One objective of this review was to study the effect of prophylaxis in both elective and non‐elective cesarean sections, and strict definitions of an elective and non‐elective cesarean section were used by the authors of this review to categorize women and studies. In 17 studies (N = 3500), data on women undergoing an elective cesarean section were available (<a href="./references#CD007482-bbs2-0001" title="AdamI , AdamES , GeraisAS . Randomized trial of ceftriaxone prophylaxis in elective cesarean section. Saudi Medical Journal2005;26(3):500‐1. ">Adam 2005</a>; <a href="./references#CD007482-bbs2-0005" title="BagrateeJ , MoodleyJ , KleinschmidtI , ZawilskiW . A randomized controlled trial of antibiotic prophylaxis in elective caesarean section. BJOG: an international journal of obstetrics and gynaecology2001;108:143‐8. BagrateeJS , MoodleyJ . Antibiotic prophylaxis in elective caesarean section. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 Oct 3‐6; Cape Town South Africa. 1999:6. ">Bagratee 2001</a>; <a href="./references#CD007482-bbs2-0015" title="DashowEE , ReadJA , ColemanFH . Randomized comparison of five irrigation solutions at cesarean section. Obstetrics &amp; Gynecology1986;68:473‐8. ">Dashow 1986</a>; <a href="./references#CD007482-bbs2-0019" title="DuffP , SmithPN , KeiserJF . Antibiotic prophylaxis in low‐risk cesarean section. Journal of Reproductive Medicine1982;27:133‐8. ">Duff 1982</a>; <a href="./references#CD007482-bbs2-0039" title="HuamSH , LimJM , RamanS . Single‐dose antibiotic prophylaxis in women undergoing elective caesarean section. Medical Journal of Malaysia1997;52:3‐7. ">Huam 1997</a>; <a href="./references#CD007482-bbs2-0041" title="JaffeR , LoebelR , AltarasM , Ben AderetN . Perioperative mezlocillin prophylaxis in cesarean section. Clinical Therapeutics1984;6(4):467‐74. ">Jaffe 1984</a>; <a href="./references#CD007482-bbs2-0043" title="JakobiP , WeissmanA , SiglerE , MargolisK , ZimmerEZ . Post‐cesarean section febrile morbidity. Journal of Reproductive Medicine1994;39:707‐10. ">Jakobi 1994</a>; <a href="./references#CD007482-bbs2-0046" title="KolbenM , MandokiE , UlmK , FreitagK . Randomized trial of cefotiam prophylaxis in the prevention of postoperative infectious morbidity after elective cesarean section. European Journal of Clinical Microbiology and Infectious Diseases2001;20:40‐2. ">Kolben 2001</a>; <a href="./references#CD007482-bbs2-0050" title="Lemus RochaR , Garcia GutierrezLB , Basavilvazo RodriguezMA , Cruz AvelarA , Peralta PedreroML , Hernandez ValenciaM . Incidence of infected surgical wound and prophylaxis with cefotaxime in cesarean section. Ginecologia y Obstetricia de Mexico2005;73(10):537‐43. ">Lemus 2005</a>; <a href="./references#CD007482-bbs2-0055" title="MahomedK . A double‐blind randomized controlled trial on the use of prophylactic antibiotics in patients undergoing elective caesarean section. British Journal of Obstetrics and Gynaecology1988;95:689‐92. ">Mahomed 1988</a>; <a href="./references#CD007482-bbs2-0069" title="RizkDEE , NsanzeH , MabroukMH , MustafaN , ThomasL , KumarM . Systemic antibiotic prophylaxis in elective cesarean delivery. International Journal of Gynecology &amp; Obstetrics1998;61(3):245‐51. ">Rizk 1998</a>; <a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>; <a href="./references#CD007482-bbs2-0073" title="RouziAA , KhalifaF , Ba'aqeelH , Al‐HamdanHS , BondagjiN . The routine use of cefazolin in cesarean section. International Journal of Gynecology and Obstetrics2000;69:107‐12. ">Rouzi 2000</a>; <a href="./references#CD007482-bbs2-0079" title="ShahS , MazherY , JohnIS . Single or triple dose piperacillin prophylaxis in elective cesarean section. International Journal of Gynecology &amp; Obstetrics1998;62(1):23‐9. ">Shah 1998</a>; <a href="./references#CD007482-bbs2-0083" title="SzillerI , KarovitsJ , ErdosiF , BekeA , OszoliG . Postoperative infectious morbidity after perioperative ampicillin /sulbactam prophylaxis in women undergoing elective caesarean section. Magyar Norvosok Lapja1994;57:101‐4. ">Sziller 1994</a>; <a href="./references#CD007482-bbs2-0087" title="UjahI , OlarewajuR . The use of prophyactic Augmentin in elective caesarean section in Jos University teaching hospital. Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992 July 7‐10; Manchester, UK. 1992:484. UjahIAO , OlarewajuRS , OtubuJAM . Prophylactic amoxicillin‐clavulanic acid in elective cesarean section. Current Therapeutic Research, Clinical and Experimental1992;52(5):647‐51. ">Ujah 1992</a>; <a href="./references#CD007482-bbs2-0093" title="WuY . Prevention of post‐operative infection by using antibiotics of 217 cases of cesarean section. Chinese Journal of Obstetrics and Gynecology1992;27:73‐5. WuY , ZhanL , JingY . Prevention of post‐operative infection by uterine and intraperitoneal irrigation with ampicillin during cesarean section. International Journal of Experimental and Clinical Chemotherapy1991;4(3):132‐6. ">Wu 1991</a>). In 22 studies (N = 2500), there were data on non‐elective procedures (<a href="./references#CD007482-bbs2-0012" title="ConoverWB , MooreTR . Comparison of irrigation and intravenous antibiotic prophylaxis at cesarean section. Obstetrical and Gynecological Survey1984;39:692‐3. ConoverWB , MooreTR . Comparison of irrigation and intravenous antibiotic prophylaxis at cesarean section. Obstetrics and Gynecology1984;63:787‐91. ">Conover 1984</a>; <a href="./references#CD007482-bbs2-0014" title="D'AngeloLJ , SokolRJ . Short‐ vs long‐course prophylactic antibiotic treatment in cesarean section patients. Obstetrics &amp; Gynecology1980;55:583‐6. ">D'Angelo 1980</a>; <a href="./references#CD007482-bbs2-0020" title="ElliottJP , FlahertyJF . Comparison of lavage or intravenous antibiotics at cesarean section. Obstetrics &amp; Gynecology1986;67:29‐32. ">Elliott 1986</a>; <a href="./references#CD007482-bbs2-0023" title="FreemanGM . The efficacy of prophylactic antibiotics in high‐risk patients undergoing cesarean section. Journal of the American Osteopathic Association1982;81(9):610‐5. ">Freeman 1982</a>; <a href="./references#CD007482-bbs2-0024" title="FugereP , TurgeonP , BoucherM , VerscheldenG , LemayM . Use of cephalosporins in antibiotic prophylaxis in women undergoing nonelective caesarean section [Utilisation des cephalosporines comme antibioprophylaxie lors de cesariennes]. Canadian Medical Association Journal1983;129:132‐5. ">Fugere 1983</a>; <a href="./references#CD007482-bbs2-0031" title="GibbsRS , StClairPJ , CastilloMS , CastanedaYS . Bacteriologic effects of antibiotic prophylaxis in high‐risk cesarean section. Obstetrics &amp; Gynecology1981;57:277‐82. ">Gibbs 1981</a>; <a href="./references#CD007482-bbs2-0036" title="HargerJH , EnglishDH . Selection of patients for antibiotic prophylaxis in cesarean sections. American Journal of Obstetrics and Gynecology1981;141:752‐8. ">Harger 1981</a>; <a href="./references#CD007482-bbs2-0037" title="HawrylyshynPA , BernsteinEP , PapsinFR . Short‐term antibiotic prophylaxis in high‐risk patients following cesarean section. American Journal of Obstetrics and Gynecology1983;145:285‐9. ">Hawrylyshyn 1983</a>; <a href="./references#CD007482-bbs2-0038" title="HeilmannL , TauberPF . Short‐term prevention with cefoxitin in cesarean section [Kurzzeitprophylaxe mit Cefoxitin beim Kaiser‐schnitt]. Geburtshilfe und Frauenheilkunde1984;44:792‐5. ">Heilmann 1984</a>; <a href="./references#CD007482-bbs2-0041" title="JaffeR , LoebelR , AltarasM , Ben AderetN . Perioperative mezlocillin prophylaxis in cesarean section. Clinical Therapeutics1984;6(4):467‐74. ">Jaffe 1984</a>; <a href="./references#CD007482-bbs2-0051" title="LeonettiHB , YunH , O'LearyJA , GreenbergAL . Single vs multiple dose piperacillin in high risk primary cesarean section. American Journal of Gynecologic Health1989;3:195‐8. ">Leonetti 1989</a>; <a href="./references#CD007482-bbs2-0058" title="MoodleyJ , ZeemanDJ . Prophylactic and antimicrobial therapy using lincomycin in patients undergoing emergency caesarean section. South African Medical Journal1981;59:911‐3. ">Moodley 1981</a>; <a href="./references#CD007482-bbs2-0071" title="RossL , MasonP , Barnet‐LambM , RobinsonRE , WarrenR . Prophylactic metronidazole in patients with ruptured membranes undergoing emergency caesarean section. Journal of Obstetrics and Gynaecology1984;5:32‐5. ">Ross 1984</a>; <a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>; <a href="./references#CD007482-bbs2-0075" title="Ruiz‐MorenoJA , Garcia‐RojasJM , Lozada‐LeonJD . Prevention of post cesarean infectious morbidity with a single dose of intravenous metronidazole. International Journal of Gynecology &amp; Obstetrics1991;34:217‐20. ">Ruiz‐Moreno 1991</a>; <a href="./references#CD007482-bbs2-0077" title="ScarpignatoC , CaltabianoM , CondemiV , MansaniFE . Short‐term vs long‐term cefuroxime prophylaxis in patients undergoing emergency cesarean section. Clinical Therapeutics1982;5:186‐92. ">Scarpignato 1982</a>; <a href="./references#CD007482-bbs2-0078" title="SchedvinsK , MobergPJ . Prevention of postoperative infection in cesarean section after rupture of the membranes. International Journal of Gynecology &amp; Obstetrics1986;24:165‐8. ">Schedvins 1986</a>; <a href="./references#CD007482-bbs2-0086" title="TzingounisV , MakrisN , ZolotasJ , MichalasS , AravantinosD . Cefuroxime prophylaxis in caesarean section. Pharmatherapeutica1982;3:140‐3. ">Tzingounis 1982</a>; <a href="./references#CD007482-bbs2-0089" title="WeissbergSM , EdwardsNL , O'LearyJA . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1971;38:290‐3. ">Weissberg 1971</a>; <a href="./references#CD007482-bbs2-0091" title="WongR , GeeCL , LedgerWJ . Prophylactic use of cefazolin in monitored obstetric patients undergoing cesarean section. Obstetrics &amp; Gynecology1978;51:407‐11. ">Wong 1978</a>; <a href="./references#CD007482-bbs2-0092" title="WorkBAJr . Role of preventive antibiotics in patients undergoing cesarean section. South African Medical Journal1977;70:44‐5. ">Work 1977</a>; <a href="./references#CD007482-bbs2-0095" title="YoungR , PlattL , LedgerW . Prophylactic cefoxitin in cesarean section. Surgery, Gynecology and Obstetrics1983;157:11‐4. ">Young 1983</a>). Two studies included both women having elective cesareans and non‐elective cesareans (<a href="./references#CD007482-bbs2-0041" title="JaffeR , LoebelR , AltarasM , Ben AderetN . Perioperative mezlocillin prophylaxis in cesarean section. Clinical Therapeutics1984;6(4):467‐74. ">Jaffe 1984</a>; <a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>). The remaining, and the majority of studies did not differentiate between an elective or non‐elective procedure, or the definitions used were not consistent with those used in this review; these have been grouped as 'both' or 'undefined'. Often a repeat section had been classified as elective by the study authors, but it was not always evident that all of these women were indeed not in labor and often the duration of membrane rupture was unclear. Fifty‐nine studies (N = 8500) included women whose procedures were classified as undefined type of cesarean section (<a href="./references#CD007482-bbs2-0002" title="AdeleyeJA , OsinusiBO . The use of prophylactic antibiotics in caesarean sections. Singapore Journal of Obstetrics and Gynaecology1981;12:29‐34. ">Adeleye 1981</a>; <a href="./references#CD007482-bbs2-0003" title="AllenJL , RamponeJF , WheelessCR . Use of a prophylactic antibiotic in elective major gynecologic operations. Obstetrics &amp; Gynecology1972;39:218‐24. ">Allen 1972</a>; <a href="./references#CD007482-bbs2-0004" title="ApuzzioJJ , GaneshVV , PelosiMA , FrisoliG . The effect of prophylactic antibiotics on risk factors for endomyometritis in adolescent patients undergoing cesarean section. Journal of Adolescent Health Care1984;5:163‐6. ApuzzioJJ , ReyeltC , PelosiM , SenP , LouriaDB . Prophylactic antibiotics for cesarean section: comparison of high‐ and low‐risk patients for endomyometritis. Obstetrics and Gynecology1982;59:693‐8. ">Apuzzio 1982</a>; <a href="./references#CD007482-bbs2-0006" title="BattarinoO , BattarinoA . Short‐term antibiotic prophylaxis in cesarean section [La profilassi antibiotica short‐time nel taglio cesareo]. Minerva Ginecologica1988;40:563‐7. ">Battarino 1988</a>; <a href="./references#CD007482-bbs2-0007" title="BibiM , MegdicheH , GhanemH , SfaxiI , NouiraM , EssaidiH , et al. Antibiotic prophylaxis in a priori cesarean sections without a high risk of infection [L'antibioprophylaxie dans les cesariennes a priori sans 'haut risque infectieux']. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1994;23:451‐5. ">Bibi 1994</a>; <a href="./references#CD007482-bbs2-0008" title="BilginT , OzanH , DirgenA , EsmerA . Comparison of four different antibiotics as prophylaxis in caesarean section. Journal of Obstetrics and Gynaecology1998;18(6):546‐7. ">Bilgin 1998</a>; <a href="./references#CD007482-bbs2-0009" title="BourgeoisFJ , PinkertonJA , AndersenW , ThiagarajahS . Antibiotic irrigation prophylaxis in the high‐risk cesarean section patient. American Journal of Obstetrics and Gynecology1985;153:197‐201. ">Bourgeois 1985</a>; <a href="./references#CD007482-bbs2-0010" title="CarlSH , HamptonR . Normal saline pelvic and intrauterine irrigation in the high‐risk cesarean section (CS) patient as a safe and cost‐effective method of infection prophylaxis. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S96. ">Carl 2000</a>; <a href="./references#CD007482-bbs2-0011" title="ChanACW , LeungAKL , ChinRKH , ChangAMZ . Single dose prophylactic antibiotics in caesarean sections. Australian and New Zealand Journal of Obstetrics and Gynaecology1989;29:107‐9. ">Chan 1989</a>; <a href="./references#CD007482-bbs2-0013" title="CormierP , LengJJ . Antibiotic prophylaxis after caesarean section [Antibioprophylaxie lors des cesariennes]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1991;20:600. CormierP , LengJJ , JankyE , DuthilB , BrousteV . Prevention of infectious complications after cesarean section by the use of cefotetan. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18:388‐92. ">Cormier 1989</a>; <a href="./references#CD007482-bbs2-0015" title="DashowEE , ReadJA , ColemanFH . Randomized comparison of five irrigation solutions at cesarean section. Obstetrics &amp; Gynecology1986;68:473‐8. ">Dashow 1986</a>; <a href="./references#CD007482-bbs2-0016" title="DeBoerCN , ThorntonJG . Prophylactic short course rectal metronidazole for cesarean section. A double‐blind controlled trial of a simple low cost regimen. International Journal of Gynecology &amp; Obstetrics1989;28:103‐7. ">De Boer 1989</a>; <a href="./references#CD007482-bbs2-0017" title="DillonWP , SeigelMS , LeleAS , O'LearyJA . Evaluation of cefoxitin prophylaxis for cesarean section. International Journal of Gynecology &amp; Obstetrics1981;19:133‐9. ">Dillon 1981</a>; <a href="./references#CD007482-bbs2-0018" title="DuffP , ParkRC . Antibiotic prophylaxis for cesarean section in a military population. Military Medicine (Washington DC)1980;145:377‐81. ">Duff 1980</a>; <a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>; <a href="./references#CD007482-bbs2-0022" title="Escobedo LobatonJM , Rodriguez HinojosaDE , Kistner GarzaAM , Benavides de AndaL . Prophylactic use of antibiotics in cesarean section [Uso profilactico de antibioticos en operacion cesarea]. Ginecologia y Obstetricia de Mexico1991;59(1):35‐8. ">Escobedo 1991</a>; <a href="./references#CD007482-bbs2-0025" title="GallSA . The efficacy of prophylactic antibiotics in caesarean section. American Journal of Obstetrics and Gynecology1979;134:506‐11. ">Gall 1979</a>; <a href="./references#CD007482-bbs2-0026" title="GaneshV , ApuzzioJJ , DispenziereB , PatelK , BergenB , LouriaDB . Single‐dose trimethoprim‐sulfamethoxazole prophylaxis for cesarean section. American Journal of Obstetrics and Gynecology1986;154:1113‐4. ">Ganesh 1986</a>; <a href="./references#CD007482-bbs2-0027" title="GarciaMH , GarciaI , DoyagueMJ , LunaS , VelascoMJ , LancharesJL , et al. Incidence of urinary infection and other infectious complications in antibiotic prophylaxis of cesaran section with ultra‐short schedule. III [Incidencia de infección urinaria y otras complicaciones infecciosas en la profilaxis antibiótica de la cesárea con pauta ultracorta. III]. Tokoginecologia Practica1992;51(7):349‐56. GarcíaMHH , LajasJA , VelascoMJ , DoyagueMJ , LunaS , GarcíaA , et al. Incidence of endometritis and infection of surgical wound in antibiotic prophylaxis of cesarean section with ultra‐short shedule. II [Incidencia de endometritis e infección en la herida oporatoria en la profilaxis antibiótica de la cesárea con pauta ultracorta. II]. Tokoginecologia Practica1992; Vol. 51:340‐8. ">Garcia 1992</a>; <a href="./references#CD007482-bbs2-0028" title="GerstnerG , KoflerE , HuberJ . Perioperative metronidazol‐prophylaxis for cesarean section. Zeitschrift fur Geburtshilfe und Perinatologie1980;184:418‐23. ">Gerstner 1980</a>; <a href="./references#CD007482-bbs2-0029" title="GibbsRS , DeCherneyAH , SchwarzRH . Prophylactic antibiotics in cesarean section: a double‐blind study. American Journal of Obstetrics and Gynecology1972;114:1048‐53. ">Gibbs 1972</a>; <a href="./references#CD007482-bbs2-0030" title="GibbsRS , HuntJE , SchwarzRH . A follow‐up study on prophylactic antibiotics in cesarean section. American Journal of Obstetrics and Gynecology1973;117:419‐22. ">Gibbs 1973</a>; <a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0033" title="GummerusM . Perioperative short‐term prophylaxis of puerperal infections following caesarean section with metronidazol. Geburtshilfe und Frauenheilkunde1984;44:570‐2. ">Gummerus 1984</a>; <a href="./references#CD007482-bbs2-0034" title="HagerWD , WilliamsonMM . Effects of antibiotic prophylaxis on women undergoing nonelective cesarean section in a community hospital. Journal of Reproductive Medicine1983;28:687‐90. ">Hager 1983</a>; <a href="./references#CD007482-bbs2-0035" title="HagglundL , ChristensenKK , ChristensenP , WestromL , IngemarssonI . Reduced rate of postoperative infections in emergency cesarean section after two doses of cefuroxim perioperatively. Acta Obstetricia et Gynecologica Scandinavica1989;68:201‐4. ">Hagglund 1989</a>; <a href="./references#CD007482-bbs2-0040" title="IsmailMA , NelsonKE , LarsonP , MosesVK . Selective effect of cefoxitin prophylaxis on post‐cesarean‐section microbial flora. Journal of Reproductive Medicine1990;35:168‐74. ">Ismail 1990</a>; <a href="./references#CD007482-bbs2-0042" title="JaffeR , AltarasM , CohenI , Ben‐AderetN . Single‐dose mezlocillin prophylaxis in emergency cesarean section. Clinical Therapeutics1985;7(4):507‐11. ">Jaffe 1985</a>; <a href="./references#CD007482-bbs2-0044" title="KarhunenM , KoskelaO , TeisalaK , SuikkariAM , MattilaJ . Prophylaxis and treatment of anaerobic infections following caesarean section with tinidazole. Chemotherapy1985;31:228‐36. ">Karhunen 1985</a>; <a href="./references#CD007482-bbs2-0045" title="KellumRB , RobertsWE , HarrisJB , KhansurN , MorrisonJC . Effect of intrauterine antibiotic lavage after cesarean birth on postoperative morbidity. Journal of Reproductive Medicine1985;30:527‐9. ">Kellum 1985</a>; <a href="./references#CD007482-bbs2-0047" title="KreutnerAK , DelBeneVE , DelamarD , HuguleyV , HarmonPM , MitchellKS . Perioperative antibiotic prophylaxis in cesarean section. Obstetrics &amp; Gynecology1978;52:279‐84. ">Kreutner 1978</a>; <a href="./references#CD007482-bbs2-0048" title="KristensenGB , BeiterEC , MatherO . Single‐dose cefuroxime prophylaxis in non‐elective cesarean section. Acta Obstetricia et Gynecologica Scandinavica1990;69:497‐500. ">Kristensen 1990</a>; <a href="./references#CD007482-bbs2-0049" title="LapasKA , TodorovI . Comparative double‐blind study of intravenous metronidazole vs placebo in preventing infection after cesarean section. Akusherstvo i Ginekologiia1988;27:46‐9. LappasCA , LeonardopoulosJ . Double‐blind comparative study of metronidazole iv vs placebo in the prophylaxis of sepsis following cesarean section. Archives of Gynecology1985;237(Suppl 1):279. ">Lapas 1988</a>; <a href="./references#CD007482-bbs2-0052" title="LevinDK , GorchelsC , AndersenR . Reduction of post‐cesarean section infectious morbidity by means of antibiotic irrigation. American Journal of Obstetrics and Gynecology1983;147:273‐7. ">Levin 1983</a>; <a href="./references#CD007482-bbs2-0053" title="LewisDF , OttersonWN , DunnihooDR . Antibiotic prophylactic uterine lavage in cesarean section: a double‐blind comparison of saline, ticarcillin, and cefoxitin irrigation in indigent patients. Southern Medical Journal1990;83:274‐6. ">Lewis 1990</a>; <a href="./references#CD007482-bbs2-0056" title="McCowanL , JacksonP . The prophylactic use of metronidazole in caesarean section. New Zealand Medical Journal1980;92:153‐5. ">McCowan 1980</a>; <a href="./references#CD007482-bbs2-0057" title="MillerRD , CrichtonD . Ampicillin prophylaxis in caesarean section. South African Journal of Obstetrics and Gynaecology1968;6:69‐70. ">Miller 1968</a>; <a href="./references#CD007482-bbs2-0059" title="MoroM , AndrewsM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1974;44:688‐92. ">Moro 1974</a>; <a href="./references#CD007482-bbs2-0060" title="MorrisonJC , CoxwellWL , KennedyBS , SchreierPC , WiserWL , FishSA . The use of prophylactic antibiotics in patients undergoing cesarean section. Surgery, Gynecology and Obstetrics1973;136:425‐8. ">Morrison 1973</a>; <a href="./references#CD007482-bbs2-0061" title="NgNK . The role of prophylactic antibiotics in caesarean section ‐ a randomized trial. Medical Journal of Malaysia1992;47:273‐9. ">Ng 1992</a>; <a href="./references#CD007482-bbs2-0062" title="OestreicherM , OestreicherS , DudenhausenJW . Prospective study on the question of single‐dose antibiotic prophylaxis for primarily indicated abdominal cesarean section (translation). Zeitschrift fur Geburtshilfe und Perinatologie1987;191:12‐4. ">Oestreicher 1987</a>; <a href="./references#CD007482-bbs2-0063" title="PadillaSL , SpenceMR , BeauchampPJ . Single‐dose ampicillin for cesarean section prophylaxis. Obstetrics &amp; Gynecology1983;61:463‐6. ">Padilla 1983</a>; <a href="./references#CD007482-bbs2-0064" title="PhelanJP , PruynSC . Prophylactic antibiotics in cesarean section: a double‐blind study of cefalozin. American Journal of Obstetrics and Gynecology1979;133:474‐8. ">Phelan 1979</a>; <a href="./references#CD007482-bbs2-0065" title="PolkBF , KracheM , PhillippeM , MunozA , HutchinsonD , MiaoL , et al. Randomized clinical trial of perioperative cefoxitin in preventing maternal infection after primary cesarean section. American Journal of Obstetrics and Gynecology1982;142:983‐7. ">Polk 1982</a>; <a href="./references#CD007482-bbs2-0066" title="MallaretMR , BlatierJF , RacinetC , FauconnierJ , FavierM , MicoudM . Economic benefit of using antibiotics prophylactically in cesarean sections with little risk of infection. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1990;19:1061‐4. RacinetC , MallaretMR , FavierM , BerthetJ , MorelI , FauconnierJ , et al. Antibiotic prophylaxis in cesarean sections without high risk of infection. Presse Medicale1990;19:1755‐8. ">Racinet 1990</a>; <a href="./references#CD007482-bbs2-0067" title="ReckelJ , ScheeleR . Perioperative antibiotic prophylaxis in cesarean section [Perioperative Antibiotikaprophylaxe bei Kaiserschnitt]. Der Klinikarzt1985;14:1054‐65. ">Reckel 1985</a>; <a href="./references#CD007482-bbs2-0068" title="RehuM , JahkolaM . Prophylactic antibiotics in caesarean section: effect of a short preoperative course of benzyl penicillin or clindamycin plus gentamicin on postoperative infectious morbidity. Annals of Clinical Research1980;12:45‐8. ">Rehu 1980</a>; <a href="./references#CD007482-bbs2-0070" title="RoexAJM , PuyenbroekJI , MacLarenDM , VanGeijnHP , ArtsNFT . A randomized clinical trial of antibiotic prophylaxis in cesarean section: maternal morbidity, risk factors and bacteriological changes. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1986;22:117‐24. RoexAJM , PuyenbroekJI , MaclarenDM , ArtsNFTh . Short‐term antibiotic prophylaxis for caesarean section [Kortdurende antibioticum profylaxe bij de section Caesarea]. Nederland Tijdschrift voor Obstetrie en Gynaecologie1987;100:105. ">Roex 1986</a>; <a href="./references#CD007482-bbs2-0073" title="RouziAA , KhalifaF , Ba'aqeelH , Al‐HamdanHS , BondagjiN . The routine use of cefazolin in cesarean section. International Journal of Gynecology and Obstetrics2000;69:107‐12. ">Rouzi 2000</a>; <a href="./references#CD007482-bbs2-0074" title="LongWH , RuddEG , DillonMB . Intrauterine irrigation with cefamandole nafate solution at cesarean section: a preliminary report. American Journal of Obstetrics and Gynecology1980;138:755‐8. RuddEG , LongWH , DillonMB . Febrile morbidity following cefamandole nafate intrauterine irrigation during cesarean section. American Journal of Obstetrics and Gynecology1981;141:12‐6. ">Rudd 1981</a>; <a href="./references#CD007482-bbs2-0076" title="SaltzmanDH , EronLJ , KayHH , SitesJG . Single‐dose antibiotic prophylaxis in high‐risk patients undergoing cesarean section. Obstetrics &amp; Gynecology1985;65:655‐7. ">Saltzman 1985</a>; <a href="./references#CD007482-bbs2-0080" title="SokolowskiVH , CanzlerE , BrotzmannC . Influence of vagimid prophylaxis on course of puerperium and healing of the wound after caesarean section in comparison with a control group. Zentralblatt fur Gynakologie1989;111:461‐5. ">Sokolowski 1989</a>; <a href="./references#CD007482-bbs2-0081" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27:113‐9. ">Stage 1982</a>; <a href="./references#CD007482-bbs2-0082" title="StiverHG , ForwardKR , LivingstoneRA , FugereP , LemayM , VerscheldenG , et al. Multicenter comparison of cefoxitin vs cefazolin for prevention of infectious morbidity after nonelective cesarean section. American Journal of Obstetrics and Gynecology1983;145:158‐63. StiverHG , ForwardKR , TyrrellDL , KripG , LivingstoneRA , FugereP , et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. American Journal of Obstetrics and Gynecology1984;149(7):718‐21. ">Stiver 1983</a>; <a href="./references#CD007482-bbs2-0084" title="TullyJL , KlapholzH , BaldiniLM , FriedlandGH . Perioperative use of cefoxitin in primary cesarean section. Journal of Reproductive Medicine1983;28:827‐32. ">Tully 1983</a>; <a href="./references#CD007482-bbs2-0085" title="TurnerMJ , EganDM , QureshiWA , SkehanM , BlackA , DarrellJH , et al. Use of cephradine prophylaxis of infection after caesarean section: stepwise logistic regression analysis of relevant factors. Journal of Obstetrics and Gynaecology1990;10:204‐9. ">Turner 1990</a>; <a href="./references#CD007482-bbs2-0088" title="Walss RodriguezR , Avila EsparzaM . Prophylactic antimicrobial therapy in cesarean section [Antibioticoterapia profilactica en operacion cesarea]. Ginecologia y Obstetricia de Mexico1990;58:79‐83. ">Walss Rodriguez 1990</a>; <a href="./references#CD007482-bbs2-0090" title="WittA , DonerM , PetricevicL , BergerA , GermannP , HeinzeG , et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double‐blind, prospective, randomized, placebo‐controlled trial. Archives of Surgery2011;146(12):1404‐9. [PUBMED: 22184305] ">Witt 2011</a>; <a href="./references#CD007482-bbs2-0094" title="YipSK , LauTK , RogersMS . A study on prophylactic antibiotics in cesarean sections ‐ is it worthwhile?. Acta Obstetricia et Gynecologica Scandinavica1997;76(6):547‐9. ">Yip 1997</a>). Two studies reported both elective and in labor/high risk (<a href="./references#CD007482-bbs2-0015" title="DashowEE , ReadJA , ColemanFH . Randomized comparison of five irrigation solutions at cesarean section. Obstetrics &amp; Gynecology1986;68:473‐8. ">Dashow 1986</a>) or emergency cesarean sections (<a href="./references#CD007482-bbs2-0073" title="RouziAA , KhalifaF , Ba'aqeelH , Al‐HamdanHS , BondagjiN . The routine use of cefazolin in cesarean section. International Journal of Gynecology and Obstetrics2000;69:107‐12. ">Rouzi 2000</a>); the in labor/high risk and emergency sections, however, did not meet our definition of non‐elective and these have been classified as "undefined" . </p> </section> <section id="CD007482-sec-0077"> <h5 class="title">Timing of antibiotic administration</h5> <p>Antibiotics for prophylaxis were administered intravenously either at the start of the operative procedure ("before cord") or at or after clamping of the cord. In 40 studies (N = 5600), data on outcomes were available when the antibiotic had been administered before clamping of the cord (<a href="./references#CD007482-bbs2-0001" title="AdamI , AdamES , GeraisAS . Randomized trial of ceftriaxone prophylaxis in elective cesarean section. Saudi Medical Journal2005;26(3):500‐1. ">Adam 2005</a>; <a href="./references#CD007482-bbs2-0002" title="AdeleyeJA , OsinusiBO . The use of prophylactic antibiotics in caesarean sections. Singapore Journal of Obstetrics and Gynaecology1981;12:29‐34. ">Adeleye 1981</a>; <a href="./references#CD007482-bbs2-0003" title="AllenJL , RamponeJF , WheelessCR . Use of a prophylactic antibiotic in elective major gynecologic operations. Obstetrics &amp; Gynecology1972;39:218‐24. ">Allen 1972</a>; <a href="./references#CD007482-bbs2-0007" title="BibiM , MegdicheH , GhanemH , SfaxiI , NouiraM , EssaidiH , et al. Antibiotic prophylaxis in a priori cesarean sections without a high risk of infection [L'antibioprophylaxie dans les cesariennes a priori sans 'haut risque infectieux']. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1994;23:451‐5. ">Bibi 1994</a>; <a href="./references#CD007482-bbs2-0011" title="ChanACW , LeungAKL , ChinRKH , ChangAMZ . Single dose prophylactic antibiotics in caesarean sections. Australian and New Zealand Journal of Obstetrics and Gynaecology1989;29:107‐9. ">Chan 1989</a>; <a href="./references#CD007482-bbs2-0016" title="DeBoerCN , ThorntonJG . Prophylactic short course rectal metronidazole for cesarean section. A double‐blind controlled trial of a simple low cost regimen. International Journal of Gynecology &amp; Obstetrics1989;28:103‐7. ">De Boer 1989</a>; <a href="./references#CD007482-bbs2-0018" title="DuffP , ParkRC . Antibiotic prophylaxis for cesarean section in a military population. Military Medicine (Washington DC)1980;145:377‐81. ">Duff 1980</a>; <a href="./references#CD007482-bbs2-0019" title="DuffP , SmithPN , KeiserJF . Antibiotic prophylaxis in low‐risk cesarean section. Journal of Reproductive Medicine1982;27:133‐8. ">Duff 1982</a>; <a href="./references#CD007482-bbs2-0023" title="FreemanGM . The efficacy of prophylactic antibiotics in high‐risk patients undergoing cesarean section. Journal of the American Osteopathic Association1982;81(9):610‐5. ">Freeman 1982</a>; <a href="./references#CD007482-bbs2-0025" title="GallSA . The efficacy of prophylactic antibiotics in caesarean section. American Journal of Obstetrics and Gynecology1979;134:506‐11. ">Gall 1979</a>; <a href="./references#CD007482-bbs2-0028" title="GerstnerG , KoflerE , HuberJ . Perioperative metronidazol‐prophylaxis for cesarean section. Zeitschrift fur Geburtshilfe und Perinatologie1980;184:418‐23. ">Gerstner 1980</a>; <a href="./references#CD007482-bbs2-0029" title="GibbsRS , DeCherneyAH , SchwarzRH . Prophylactic antibiotics in cesarean section: a double‐blind study. American Journal of Obstetrics and Gynecology1972;114:1048‐53. ">Gibbs 1972</a>; <a href="./references#CD007482-bbs2-0030" title="GibbsRS , HuntJE , SchwarzRH . A follow‐up study on prophylactic antibiotics in cesarean section. American Journal of Obstetrics and Gynecology1973;117:419‐22. ">Gibbs 1973</a>;<a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0035" title="HagglundL , ChristensenKK , ChristensenP , WestromL , IngemarssonI . Reduced rate of postoperative infections in emergency cesarean section after two doses of cefuroxim perioperatively. Acta Obstetricia et Gynecologica Scandinavica1989;68:201‐4. ">Hagglund 1989</a>; <a href="./references#CD007482-bbs2-0038" title="HeilmannL , TauberPF . Short‐term prevention with cefoxitin in cesarean section [Kurzzeitprophylaxe mit Cefoxitin beim Kaiser‐schnitt]. Geburtshilfe und Frauenheilkunde1984;44:792‐5. ">Heilmann 1984</a>; <a href="./references#CD007482-bbs2-0039" title="HuamSH , LimJM , RamanS . Single‐dose antibiotic prophylaxis in women undergoing elective caesarean section. Medical Journal of Malaysia1997;52:3‐7. ">Huam 1997</a>; <a href="./references#CD007482-bbs2-0041" title="JaffeR , LoebelR , AltarasM , Ben AderetN . Perioperative mezlocillin prophylaxis in cesarean section. Clinical Therapeutics1984;6(4):467‐74. ">Jaffe 1984</a>; <a href="./references#CD007482-bbs2-0042" title="JaffeR , AltarasM , CohenI , Ben‐AderetN . Single‐dose mezlocillin prophylaxis in emergency cesarean section. Clinical Therapeutics1985;7(4):507‐11. ">Jaffe 1985</a>; <a href="./references#CD007482-bbs2-0047" title="KreutnerAK , DelBeneVE , DelamarD , HuguleyV , HarmonPM , MitchellKS . Perioperative antibiotic prophylaxis in cesarean section. Obstetrics &amp; Gynecology1978;52:279‐84. ">Kreutner 1978</a>; <a href="./references#CD007482-bbs2-0049" title="LapasKA , TodorovI . Comparative double‐blind study of intravenous metronidazole vs placebo in preventing infection after cesarean section. Akusherstvo i Ginekologiia1988;27:46‐9. LappasCA , LeonardopoulosJ . Double‐blind comparative study of metronidazole iv vs placebo in the prophylaxis of sepsis following cesarean section. Archives of Gynecology1985;237(Suppl 1):279. ">Lapas 1988</a>; <a href="./references#CD007482-bbs2-0054" title="MagroB , FranchiI , ChehadeA , BertiMA , CoppiG . A controlled clinical study of cefuroxim for antimicrobial prophylaxis during obstetric and gynecological surgery [Studio clinico controllato del cefuroxim nella profilassi antimicrobia durante gli interventi chirurgici in ostetricia e ginecologia]. Clinica Terapeutica1983;105(3):209‐14. ">Magro 1983</a>; <a href="./references#CD007482-bbs2-0055" title="MahomedK . A double‐blind randomized controlled trial on the use of prophylactic antibiotics in patients undergoing elective caesarean section. British Journal of Obstetrics and Gynaecology1988;95:689‐92. ">Mahomed 1988</a>; <a href="./references#CD007482-bbs2-0056" title="McCowanL , JacksonP . The prophylactic use of metronidazole in caesarean section. New Zealand Medical Journal1980;92:153‐5. ">McCowan 1980</a>: <a href="./references#CD007482-bbs2-0057" title="MillerRD , CrichtonD . Ampicillin prophylaxis in caesarean section. South African Journal of Obstetrics and Gynaecology1968;6:69‐70. ">Miller 1968</a>; <a href="./references#CD007482-bbs2-0058" title="MoodleyJ , ZeemanDJ . Prophylactic and antimicrobial therapy using lincomycin in patients undergoing emergency caesarean section. South African Medical Journal1981;59:911‐3. ">Moodley 1981</a>; <a href="./references#CD007482-bbs2-0059" title="MoroM , AndrewsM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1974;44:688‐92. ">Moro 1974</a>; <a href="./references#CD007482-bbs2-0060" title="MorrisonJC , CoxwellWL , KennedyBS , SchreierPC , WiserWL , FishSA . The use of prophylactic antibiotics in patients undergoing cesarean section. Surgery, Gynecology and Obstetrics1973;136:425‐8. ">Morrison 1973</a>; <a href="./references#CD007482-bbs2-0061" title="NgNK . The role of prophylactic antibiotics in caesarean section ‐ a randomized trial. Medical Journal of Malaysia1992;47:273‐9. ">Ng 1992</a>; <a href="./references#CD007482-bbs2-0064" title="PhelanJP , PruynSC . Prophylactic antibiotics in cesarean section: a double‐blind study of cefalozin. American Journal of Obstetrics and Gynecology1979;133:474‐8. ">Phelan 1979</a>; <a href="./references#CD007482-bbs2-0067" title="ReckelJ , ScheeleR . Perioperative antibiotic prophylaxis in cesarean section [Perioperative Antibiotikaprophylaxe bei Kaiserschnitt]. Der Klinikarzt1985;14:1054‐65. ">Reckel 1985</a>; <a href="./references#CD007482-bbs2-0068" title="RehuM , JahkolaM . Prophylactic antibiotics in caesarean section: effect of a short preoperative course of benzyl penicillin or clindamycin plus gentamicin on postoperative infectious morbidity. Annals of Clinical Research1980;12:45‐8. ">Rehu 1980</a>; <a href="./references#CD007482-bbs2-0071" title="RossL , MasonP , Barnet‐LambM , RobinsonRE , WarrenR . Prophylactic metronidazole in patients with ruptured membranes undergoing emergency caesarean section. Journal of Obstetrics and Gynaecology1984;5:32‐5. ">Ross 1984</a>; <a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>; <a href="./references#CD007482-bbs2-0081" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27:113‐9. ">Stage 1982</a>; <a href="./references#CD007482-bbs2-0085" title="TurnerMJ , EganDM , QureshiWA , SkehanM , BlackA , DarrellJH , et al. Use of cephradine prophylaxis of infection after caesarean section: stepwise logistic regression analysis of relevant factors. Journal of Obstetrics and Gynaecology1990;10:204‐9. ">Turner 1990</a>; <a href="./references#CD007482-bbs2-0086" title="TzingounisV , MakrisN , ZolotasJ , MichalasS , AravantinosD . Cefuroxime prophylaxis in caesarean section. Pharmatherapeutica1982;3:140‐3. ">Tzingounis 1982</a>; <a href="./references#CD007482-bbs2-0090" title="WittA , DonerM , PetricevicL , BergerA , GermannP , HeinzeG , et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double‐blind, prospective, randomized, placebo‐controlled trial. Archives of Surgery2011;146(12):1404‐9. [PUBMED: 22184305] ">Witt 2011</a>; <a href="./references#CD007482-bbs2-0092" title="WorkBAJr . Role of preventive antibiotics in patients undergoing cesarean section. South African Medical Journal1977;70:44‐5. ">Work 1977</a>; <a href="./references#CD007482-bbs2-0094" title="YipSK , LauTK , RogersMS . A study on prophylactic antibiotics in cesarean sections ‐ is it worthwhile?. Acta Obstetricia et Gynecologica Scandinavica1997;76(6):547‐9. ">Yip 1997</a>). This was variably described as "pre‐operatively", "with induction of anaesthesia" or "before clamping of the cord". In 51 studies (N = 8400), the antibiotic was administered at or after cord clamping (<a href="./references#CD007482-bbs2-0004" title="ApuzzioJJ , GaneshVV , PelosiMA , FrisoliG . The effect of prophylactic antibiotics on risk factors for endomyometritis in adolescent patients undergoing cesarean section. Journal of Adolescent Health Care1984;5:163‐6. ApuzzioJJ , ReyeltC , PelosiM , SenP , LouriaDB . Prophylactic antibiotics for cesarean section: comparison of high‐ and low‐risk patients for endomyometritis. Obstetrics and Gynecology1982;59:693‐8. ">Apuzzio 1982</a>; <a href="./references#CD007482-bbs2-0005" title="BagrateeJ , MoodleyJ , KleinschmidtI , ZawilskiW . A randomized controlled trial of antibiotic prophylaxis in elective caesarean section. BJOG: an international journal of obstetrics and gynaecology2001;108:143‐8. BagrateeJS , MoodleyJ . Antibiotic prophylaxis in elective caesarean section. Women's Health ‐ into the new millenium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 Oct 3‐6; Cape Town South Africa. 1999:6. ">Bagratee 2001</a>; <a href="./references#CD007482-bbs2-0006" title="BattarinoO , BattarinoA . Short‐term antibiotic prophylaxis in cesarean section [La profilassi antibiotica short‐time nel taglio cesareo]. Minerva Ginecologica1988;40:563‐7. ">Battarino 1988</a>; <a href="./references#CD007482-bbs2-0009" title="BourgeoisFJ , PinkertonJA , AndersenW , ThiagarajahS . Antibiotic irrigation prophylaxis in the high‐risk cesarean section patient. American Journal of Obstetrics and Gynecology1985;153:197‐201. ">Bourgeois 1985</a>; <a href="./references#CD007482-bbs2-0008" title="BilginT , OzanH , DirgenA , EsmerA . Comparison of four different antibiotics as prophylaxis in caesarean section. Journal of Obstetrics and Gynaecology1998;18(6):546‐7. ">Bilgin 1998</a>; <a href="./references#CD007482-bbs2-0010" title="CarlSH , HamptonR . Normal saline pelvic and intrauterine irrigation in the high‐risk cesarean section (CS) patient as a safe and cost‐effective method of infection prophylaxis. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S96. ">Carl 2000</a>; <a href="./references#CD007482-bbs2-0012" title="ConoverWB , MooreTR . Comparison of irrigation and intravenous antibiotic prophylaxis at cesarean section. Obstetrical and Gynecological Survey1984;39:692‐3. ConoverWB , MooreTR . Comparison of irrigation and intravenous antibiotic prophylaxis at cesarean section. Obstetrics and Gynecology1984;63:787‐91. ">Conover 1984</a>; <a href="./references#CD007482-bbs2-0013" title="CormierP , LengJJ . Antibiotic prophylaxis after caesarean section [Antibioprophylaxie lors des cesariennes]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction1991;20:600. CormierP , LengJJ , JankyE , DuthilB , BrousteV . Prevention of infectious complications after cesarean section by the use of cefotetan. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1989;18:388‐92. ">Cormier 1989</a>; <a href="./references#CD007482-bbs2-0014" title="D'AngeloLJ , SokolRJ . Short‐ vs long‐course prophylactic antibiotic treatment in cesarean section patients. Obstetrics &amp; Gynecology1980;55:583‐6. ">D'Angelo 1980</a>; <a href="./references#CD007482-bbs2-0015" title="DashowEE , ReadJA , ColemanFH . Randomized comparison of five irrigation solutions at cesarean section. Obstetrics &amp; Gynecology1986;68:473‐8. ">Dashow 1986</a>; <a href="./references#CD007482-bbs2-0017" title="DillonWP , SeigelMS , LeleAS , O'LearyJA . Evaluation of cefoxitin prophylaxis for cesarean section. International Journal of Gynecology &amp; Obstetrics1981;19:133‐9. ">Dillon 1981</a>; <a href="./references#CD007482-bbs2-0020" title="ElliottJP , FlahertyJF . Comparison of lavage or intravenous antibiotics at cesarean section. Obstetrics &amp; Gynecology1986;67:29‐32. ">Elliott 1986</a>; <a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>; <a href="./references#CD007482-bbs2-0022" title="Escobedo LobatonJM , Rodriguez HinojosaDE , Kistner GarzaAM , Benavides de AndaL . Prophylactic use of antibiotics in cesarean section [Uso profilactico de antibioticos en operacion cesarea]. Ginecologia y Obstetricia de Mexico1991;59(1):35‐8. ">Escobedo 1991</a>; <a href="./references#CD007482-bbs2-0024" title="FugereP , TurgeonP , BoucherM , VerscheldenG , LemayM . Use of cephalosporins in antibiotic prophylaxis in women undergoing nonelective caesarean section [Utilisation des cephalosporines comme antibioprophylaxie lors de cesariennes]. Canadian Medical Association Journal1983;129:132‐5. ">Fugere 1983</a>; <a href="./references#CD007482-bbs2-0026" title="GaneshV , ApuzzioJJ , DispenziereB , PatelK , BergenB , LouriaDB . Single‐dose trimethoprim‐sulfamethoxazole prophylaxis for cesarean section. American Journal of Obstetrics and Gynecology1986;154:1113‐4. ">Ganesh 1986</a>; <a href="./references#CD007482-bbs2-0027" title="GarciaMH , GarciaI , DoyagueMJ , LunaS , VelascoMJ , LancharesJL , et al. Incidence of urinary infection and other infectious complications in antibiotic prophylaxis of cesaran section with ultra‐short schedule. III [Incidencia de infección urinaria y otras complicaciones infecciosas en la profilaxis antibiótica de la cesárea con pauta ultracorta. III]. Tokoginecologia Practica1992;51(7):349‐56. GarcíaMHH , LajasJA , VelascoMJ , DoyagueMJ , LunaS , GarcíaA , et al. Incidence of endometritis and infection of surgical wound in antibiotic prophylaxis of cesarean section with ultra‐short shedule. II [Incidencia de endometritis e infección en la herida oporatoria en la profilaxis antibiótica de la cesárea con pauta ultracorta. II]. Tokoginecologia Practica1992; Vol. 51:340‐8. ">Garcia 1992</a>; <a href="./references#CD007482-bbs2-0031" title="GibbsRS , StClairPJ , CastilloMS , CastanedaYS . Bacteriologic effects of antibiotic prophylaxis in high‐risk cesarean section. Obstetrics &amp; Gynecology1981;57:277‐82. ">Gibbs 1981</a>; <a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0033" title="GummerusM . Perioperative short‐term prophylaxis of puerperal infections following caesarean section with metronidazol. Geburtshilfe und Frauenheilkunde1984;44:570‐2. ">Gummerus 1984</a>; <a href="./references#CD007482-bbs2-0034" title="HagerWD , WilliamsonMM . Effects of antibiotic prophylaxis on women undergoing nonelective cesarean section in a community hospital. Journal of Reproductive Medicine1983;28:687‐90. ">Hager 1983</a>; <a href="./references#CD007482-bbs2-0036" title="HargerJH , EnglishDH . Selection of patients for antibiotic prophylaxis in cesarean sections. American Journal of Obstetrics and Gynecology1981;141:752‐8. ">Harger 1981</a>; <a href="./references#CD007482-bbs2-0037" title="HawrylyshynPA , BernsteinEP , PapsinFR . Short‐term antibiotic prophylaxis in high‐risk patients following cesarean section. American Journal of Obstetrics and Gynecology1983;145:285‐9. ">Hawrylyshyn 1983</a>; <a href="./references#CD007482-bbs2-0040" title="IsmailMA , NelsonKE , LarsonP , MosesVK . Selective effect of cefoxitin prophylaxis on post‐cesarean‐section microbial flora. Journal of Reproductive Medicine1990;35:168‐74. ">Ismail 1990</a>; <a href="./references#CD007482-bbs2-0043" title="JakobiP , WeissmanA , SiglerE , MargolisK , ZimmerEZ . Post‐cesarean section febrile morbidity. Journal of Reproductive Medicine1994;39:707‐10. ">Jakobi 1994</a>; <a href="./references#CD007482-bbs2-0044" title="KarhunenM , KoskelaO , TeisalaK , SuikkariAM , MattilaJ . Prophylaxis and treatment of anaerobic infections following caesarean section with tinidazole. Chemotherapy1985;31:228‐36. ">Karhunen 1985</a>; <a href="./references#CD007482-bbs2-0045" title="KellumRB , RobertsWE , HarrisJB , KhansurN , MorrisonJC . Effect of intrauterine antibiotic lavage after cesarean birth on postoperative morbidity. Journal of Reproductive Medicine1985;30:527‐9. ">Kellum 1985</a>; <a href="./references#CD007482-bbs2-0048" title="KristensenGB , BeiterEC , MatherO . Single‐dose cefuroxime prophylaxis in non‐elective cesarean section. Acta Obstetricia et Gynecologica Scandinavica1990;69:497‐500. ">Kristensen 1990</a>; <a href="./references#CD007482-bbs2-0050" title="Lemus RochaR , Garcia GutierrezLB , Basavilvazo RodriguezMA , Cruz AvelarA , Peralta PedreroML , Hernandez ValenciaM . Incidence of infected surgical wound and prophylaxis with cefotaxime in cesarean section. Ginecologia y Obstetricia de Mexico2005;73(10):537‐43. ">Lemus 2005</a>; <a href="./references#CD007482-bbs2-0051" title="LeonettiHB , YunH , O'LearyJA , GreenbergAL . Single vs multiple dose piperacillin in high risk primary cesarean section. American Journal of Gynecologic Health1989;3:195‐8. ">Leonetti 1989</a>; <a href="./references#CD007482-bbs2-0052" title="LevinDK , GorchelsC , AndersenR . Reduction of post‐cesarean section infectious morbidity by means of antibiotic irrigation. American Journal of Obstetrics and Gynecology1983;147:273‐7. ">Levin 1983</a>; <a href="./references#CD007482-bbs2-0053" title="LewisDF , OttersonWN , DunnihooDR . Antibiotic prophylactic uterine lavage in cesarean section: a double‐blind comparison of saline, ticarcillin, and cefoxitin irrigation in indigent patients. Southern Medical Journal1990;83:274‐6. ">Lewis 1990</a>; <a href="./references#CD007482-bbs2-0062" title="OestreicherM , OestreicherS , DudenhausenJW . Prospective study on the question of single‐dose antibiotic prophylaxis for primarily indicated abdominal cesarean section (translation). Zeitschrift fur Geburtshilfe und Perinatologie1987;191:12‐4. ">Oestreicher 1987</a>; <a href="./references#CD007482-bbs2-0065" title="PolkBF , KracheM , PhillippeM , MunozA , HutchinsonD , MiaoL , et al. Randomized clinical trial of perioperative cefoxitin in preventing maternal infection after primary cesarean section. American Journal of Obstetrics and Gynecology1982;142:983‐7. ">Polk 1982</a>; <a href="./references#CD007482-bbs2-0066" title="MallaretMR , BlatierJF , RacinetC , FauconnierJ , FavierM , MicoudM . Economic benefit of using antibiotics prophylactically in cesarean sections with little risk of infection. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1990;19:1061‐4. RacinetC , MallaretMR , FavierM , BerthetJ , MorelI , FauconnierJ , et al. Antibiotic prophylaxis in cesarean sections without high risk of infection. Presse Medicale1990;19:1755‐8. ">Racinet 1990</a>; <a href="./references#CD007482-bbs2-0069" title="RizkDEE , NsanzeH , MabroukMH , MustafaN , ThomasL , KumarM . Systemic antibiotic prophylaxis in elective cesarean delivery. International Journal of Gynecology &amp; Obstetrics1998;61(3):245‐51. ">Rizk 1998</a>; <a href="./references#CD007482-bbs2-0070" title="RoexAJM , PuyenbroekJI , MacLarenDM , VanGeijnHP , ArtsNFT . A randomized clinical trial of antibiotic prophylaxis in cesarean section: maternal morbidity, risk factors and bacteriological changes. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1986;22:117‐24. RoexAJM , PuyenbroekJI , MaclarenDM , ArtsNFTh . Short‐term antibiotic prophylaxis for caesarean section [Kortdurende antibioticum profylaxe bij de section Caesarea]. Nederland Tijdschrift voor Obstetrie en Gynaecologie1987;100:105. ">Roex 1986</a>; <a href="./references#CD007482-bbs2-0073" title="RouziAA , KhalifaF , Ba'aqeelH , Al‐HamdanHS , BondagjiN . The routine use of cefazolin in cesarean section. International Journal of Gynecology and Obstetrics2000;69:107‐12. ">Rouzi 2000</a>; <a href="./references#CD007482-bbs2-0074" title="LongWH , RuddEG , DillonMB . Intrauterine irrigation with cefamandole nafate solution at cesarean section: a preliminary report. American Journal of Obstetrics and Gynecology1980;138:755‐8. RuddEG , LongWH , DillonMB . Febrile morbidity following cefamandole nafate intrauterine irrigation during cesarean section. American Journal of Obstetrics and Gynecology1981;141:12‐6. ">Rudd 1981</a>; <a href="./references#CD007482-bbs2-0075" title="Ruiz‐MorenoJA , Garcia‐RojasJM , Lozada‐LeonJD . Prevention of post cesarean infectious morbidity with a single dose of intravenous metronidazole. International Journal of Gynecology &amp; Obstetrics1991;34:217‐20. ">Ruiz‐Moreno 1991</a>; <a href="./references#CD007482-bbs2-0076" title="SaltzmanDH , EronLJ , KayHH , SitesJG . Single‐dose antibiotic prophylaxis in high‐risk patients undergoing cesarean section. Obstetrics &amp; Gynecology1985;65:655‐7. ">Saltzman 1985</a>; <a href="./references#CD007482-bbs2-0079" title="ShahS , MazherY , JohnIS . Single or triple dose piperacillin prophylaxis in elective cesarean section. International Journal of Gynecology &amp; Obstetrics1998;62(1):23‐9. ">Shah 1998</a>; <a href="./references#CD007482-bbs2-0080" title="SokolowskiVH , CanzlerE , BrotzmannC . Influence of vagimid prophylaxis on course of puerperium and healing of the wound after caesarean section in comparison with a control group. Zentralblatt fur Gynakologie1989;111:461‐5. ">Sokolowski 1989</a>; <a href="./references#CD007482-bbs2-0082" title="StiverHG , ForwardKR , LivingstoneRA , FugereP , LemayM , VerscheldenG , et al. Multicenter comparison of cefoxitin vs cefazolin for prevention of infectious morbidity after nonelective cesarean section. American Journal of Obstetrics and Gynecology1983;145:158‐63. StiverHG , ForwardKR , TyrrellDL , KripG , LivingstoneRA , FugereP , et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. American Journal of Obstetrics and Gynecology1984;149(7):718‐21. ">Stiver 1983</a>; <a href="./references#CD007482-bbs2-0083" title="SzillerI , KarovitsJ , ErdosiF , BekeA , OszoliG . Postoperative infectious morbidity after perioperative ampicillin /sulbactam prophylaxis in women undergoing elective caesarean section. Magyar Norvosok Lapja1994;57:101‐4. ">Sziller 1994</a>; <a href="./references#CD007482-bbs2-0084" title="TullyJL , KlapholzH , BaldiniLM , FriedlandGH . Perioperative use of cefoxitin in primary cesarean section. Journal of Reproductive Medicine1983;28:827‐32. ">Tully 1983</a>; <a href="./references#CD007482-bbs2-0088" title="Walss RodriguezR , Avila EsparzaM . Prophylactic antimicrobial therapy in cesarean section [Antibioticoterapia profilactica en operacion cesarea]. Ginecologia y Obstetricia de Mexico1990;58:79‐83. ">Walss Rodriguez 1990</a>; <a href="./references#CD007482-bbs2-0090" title="WittA , DonerM , PetricevicL , BergerA , GermannP , HeinzeG , et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double‐blind, prospective, randomized, placebo‐controlled trial. Archives of Surgery2011;146(12):1404‐9. [PUBMED: 22184305] ">Witt 2011</a>; <a href="./references#CD007482-bbs2-0091" title="WongR , GeeCL , LedgerWJ . Prophylactic use of cefazolin in monitored obstetric patients undergoing cesarean section. Obstetrics &amp; Gynecology1978;51:407‐11. ">Wong 1978</a>; <a href="./references#CD007482-bbs2-0093" title="WuY . Prevention of post‐operative infection by using antibiotics of 217 cases of cesarean section. Chinese Journal of Obstetrics and Gynecology1992;27:73‐5. WuY , ZhanL , JingY . Prevention of post‐operative infection by uterine and intraperitoneal irrigation with ampicillin during cesarean section. International Journal of Experimental and Clinical Chemotherapy1991;4(3):132‐6. ">Wu 1991</a>; <a href="./references#CD007482-bbs2-0095" title="YoungR , PlattL , LedgerW . Prophylactic cefoxitin in cesarean section. Surgery, Gynecology and Obstetrics1983;157:11‐4. ">Young 1983</a>). Included in this group were studies where irrigation of the peritoneal or uterine cavity with an antibiotic containing solution was compared with either saline irrigation or no irrigation (<a href="./references#CD007482-bbs2-0009" title="BourgeoisFJ , PinkertonJA , AndersenW , ThiagarajahS . Antibiotic irrigation prophylaxis in the high‐risk cesarean section patient. American Journal of Obstetrics and Gynecology1985;153:197‐201. ">Bourgeois 1985</a>; <a href="./references#CD007482-bbs2-0010" title="CarlSH , HamptonR . Normal saline pelvic and intrauterine irrigation in the high‐risk cesarean section (CS) patient as a safe and cost‐effective method of infection prophylaxis. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S96. ">Carl 2000</a>; <a href="./references#CD007482-bbs2-0012" title="ConoverWB , MooreTR . Comparison of irrigation and intravenous antibiotic prophylaxis at cesarean section. Obstetrical and Gynecological Survey1984;39:692‐3. ConoverWB , MooreTR . Comparison of irrigation and intravenous antibiotic prophylaxis at cesarean section. Obstetrics and Gynecology1984;63:787‐91. ">Conover 1984</a>; <a href="./references#CD007482-bbs2-0015" title="DashowEE , ReadJA , ColemanFH . Randomized comparison of five irrigation solutions at cesarean section. Obstetrics &amp; Gynecology1986;68:473‐8. ">Dashow 1986</a>; <a href="./references#CD007482-bbs2-0020" title="ElliottJP , FlahertyJF . Comparison of lavage or intravenous antibiotics at cesarean section. Obstetrics &amp; Gynecology1986;67:29‐32. ">Elliott 1986</a>; <a href="./references#CD007482-bbs2-0045" title="KellumRB , RobertsWE , HarrisJB , KhansurN , MorrisonJC . Effect of intrauterine antibiotic lavage after cesarean birth on postoperative morbidity. Journal of Reproductive Medicine1985;30:527‐9. ">Kellum 1985</a>; <a href="./references#CD007482-bbs2-0052" title="LevinDK , GorchelsC , AndersenR . Reduction of post‐cesarean section infectious morbidity by means of antibiotic irrigation. American Journal of Obstetrics and Gynecology1983;147:273‐7. ">Levin 1983</a>; <a href="./references#CD007482-bbs2-0053" title="LewisDF , OttersonWN , DunnihooDR . Antibiotic prophylactic uterine lavage in cesarean section: a double‐blind comparison of saline, ticarcillin, and cefoxitin irrigation in indigent patients. Southern Medical Journal1990;83:274‐6. ">Lewis 1990</a>; <a href="./references#CD007482-bbs2-0074" title="LongWH , RuddEG , DillonMB . Intrauterine irrigation with cefamandole nafate solution at cesarean section: a preliminary report. American Journal of Obstetrics and Gynecology1980;138:755‐8. RuddEG , LongWH , DillonMB . Febrile morbidity following cefamandole nafate intrauterine irrigation during cesarean section. American Journal of Obstetrics and Gynecology1981;141:12‐6. ">Rudd 1981</a>; <a href="./references#CD007482-bbs2-0093" title="WuY . Prevention of post‐operative infection by using antibiotics of 217 cases of cesarean section. Chinese Journal of Obstetrics and Gynecology1992;27:73‐5. WuY , ZhanL , JingY . Prevention of post‐operative infection by uterine and intraperitoneal irrigation with ampicillin during cesarean section. International Journal of Experimental and Clinical Chemotherapy1991;4(3):132‐6. ">Wu 1991</a>). There were six studies where there was insufficient information to know when the antibiotic had been administered, e.g. "operatively" or the results had been combined and these have been grouped together as "timing not defined" (<a href="./references#CD007482-bbs2-0046" title="KolbenM , MandokiE , UlmK , FreitagK . Randomized trial of cefotiam prophylaxis in the prevention of postoperative infectious morbidity after elective cesarean section. European Journal of Clinical Microbiology and Infectious Diseases2001;20:40‐2. ">Kolben 2001</a>; <a href="./references#CD007482-bbs2-0063" title="PadillaSL , SpenceMR , BeauchampPJ . Single‐dose ampicillin for cesarean section prophylaxis. Obstetrics &amp; Gynecology1983;61:463‐6. ">Padilla 1983</a>; <a href="./references#CD007482-bbs2-0077" title="ScarpignatoC , CaltabianoM , CondemiV , MansaniFE . Short‐term vs long‐term cefuroxime prophylaxis in patients undergoing emergency cesarean section. Clinical Therapeutics1982;5:186‐92. ">Scarpignato 1982</a>; <a href="./references#CD007482-bbs2-0078" title="SchedvinsK , MobergPJ . Prevention of postoperative infection in cesarean section after rupture of the membranes. International Journal of Gynecology &amp; Obstetrics1986;24:165‐8. ">Schedvins 1986</a>; <a href="./references#CD007482-bbs2-0087" title="UjahI , OlarewajuR . The use of prophyactic Augmentin in elective caesarean section in Jos University teaching hospital. Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992 July 7‐10; Manchester, UK. 1992:484. UjahIAO , OlarewajuRS , OtubuJAM . Prophylactic amoxicillin‐clavulanic acid in elective cesarean section. Current Therapeutic Research, Clinical and Experimental1992;52(5):647‐51. ">Ujah 1992</a>; <a href="./references#CD007482-bbs2-0089" title="WeissbergSM , EdwardsNL , O'LearyJA . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1971;38:290‐3. ">Weissberg 1971</a>). In two studies, results were available for antibiotic administration both before and after clamping of the cord (<a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0090" title="WittA , DonerM , PetricevicL , BergerA , GermannP , HeinzeG , et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double‐blind, prospective, randomized, placebo‐controlled trial. Archives of Surgery2011;146(12):1404‐9. [PUBMED: 22184305] ">Witt 2011</a>). </p> </section> <section id="CD007482-sec-0078"> <h5 class="title">Classes of antibiotics</h5> <p>The antimicrobial agents most often used in the trials included ampicillin, a first generation cephalosporin (usually cefazolin), a second generation cephalosporin (cefamandole or cefuroxime) or a cefamycin (cefoxitin, cefotetan), metronidazole, penicillins with an extended spectrum of activity (e.g. ticarcillin, mezlocillin or pipericillin), a beta‐lactam/beta‐lactamase inhibitor combination and an aminoglycoside‐containing combination; <i>see</i><a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a> for a classification of the antimicrobial agent used by antibiotic class. The penicillins have been divided into natural penicillin, penicillinase‐resistant penicillins, aminopenicilins (ampicillin), extended spectrum penicillins which include carboxypenicillins (carbenicillin, ticarcillin) and ureidopenicillins (mezlocillin, pipericillin) and beta‐lactam‐beta‐lactamase inhibitor combinations. The second generation cephalosporins include the cefamycins (cefoxitin and cefotetan) that have extended anaerobic coverage. In one study antimicrobial prophylaxis was administered by rectal suppository (<a href="./references#CD007482-bbs2-0016" title="DeBoerCN , ThorntonJG . Prophylactic short course rectal metronidazole for cesarean section. A double‐blind controlled trial of a simple low cost regimen. International Journal of Gynecology &amp; Obstetrics1989;28:103‐7. ">De Boer 1989</a>) and in four studies follow‐up doses were administered by rectal suppository (<a href="./references#CD007482-bbs2-0028" title="GerstnerG , KoflerE , HuberJ . Perioperative metronidazol‐prophylaxis for cesarean section. Zeitschrift fur Geburtshilfe und Perinatologie1980;184:418‐23. ">Gerstner 1980</a>; <a href="./references#CD007482-bbs2-0056" title="McCowanL , JacksonP . The prophylactic use of metronidazole in caesarean section. New Zealand Medical Journal1980;92:153‐5. ">McCowan 1980</a>; <a href="./references#CD007482-bbs2-0071" title="RossL , MasonP , Barnet‐LambM , RobinsonRE , WarrenR . Prophylactic metronidazole in patients with ruptured membranes undergoing emergency caesarean section. Journal of Obstetrics and Gynaecology1984;5:32‐5. ">Ross 1984</a>) or vaginal tablet (<a href="./references#CD007482-bbs2-0080" title="SokolowskiVH , CanzlerE , BrotzmannC . Influence of vagimid prophylaxis on course of puerperium and healing of the wound after caesarean section in comparison with a control group. Zentralblatt fur Gynakologie1989;111:461‐5. ">Sokolowski 1989</a>). The duration of the post‐operative treatment course varied from a single intravenous dose to as long as a week. While most studies were published in the 1980s, new studies have continued to be performed in the 1990s and the last study was published as recently as 2011. </p> </section> <section id="CD007482-sec-0079"> <h5 class="title">Assessing outcomes</h5> <p>The clinical criteria listed to define endometritis were consistent across trials. Febrile morbidity is a standard obstetrical outcome and was generally consistently reported although there was some variation in the exact criteria used for height of fever, interval between febrile episodes and interval from the operative procedure. Urinary tract infection generally meant a positive urine culture; symptoms related to the urinary tract were rarely required to be present. Wound infection usually was a clinical diagnosis and generally included induration, erythema, cellulitis or various degrees of drainage. A positive microbiological diagnosis was rarely required for the diagnosis of either wound infection or endometritis. There was no consistent approach to the definition of serious infectious morbidity. For this review, all episodes of bacteremia have been classified as serious as have other complications such as pelvic abscess, pelvic thrombophlebitis and peritonitis. Some studies included other outcomes, e.g. need for additional antibiotic use and other infections, e.g. pneumonia. Some provided a measure of the fever as a 'fever index' which incorporated both the height of the fever and its duration. Where the duration of maternal hospital stay with its standard deviation was reported, this has been included. </p> </section> <section id="CD007482-sec-0080"> <h5 class="title">Side effects</h5> <p>Very few studies appeared to have consistently sought maternal side effects or neonatal/infant side effects and similarly it was a minority of studies that collected data on infectious complications after discharge. </p> </section> <section id="CD007482-sec-0081"> <h5 class="title">Costs</h5> <p>Three studies compared the cost of antibiotics between groups (<a href="./references#CD007482-bbs2-0007" title="BibiM , MegdicheH , GhanemH , SfaxiI , NouiraM , EssaidiH , et al. Antibiotic prophylaxis in a priori cesarean sections without a high risk of infection [L'antibioprophylaxie dans les cesariennes a priori sans 'haut risque infectieux']. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1994;23:451‐5. ">Bibi 1994</a>; <a href="./references#CD007482-bbs2-0048" title="KristensenGB , BeiterEC , MatherO . Single‐dose cefuroxime prophylaxis in non‐elective cesarean section. Acta Obstetricia et Gynecologica Scandinavica1990;69:497‐500. ">Kristensen 1990</a>; <a href="./references#CD007482-bbs2-0066" title="MallaretMR , BlatierJF , RacinetC , FauconnierJ , FavierM , MicoudM . Economic benefit of using antibiotics prophylactically in cesarean sections with little risk of infection. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1990;19:1061‐4. RacinetC , MallaretMR , FavierM , BerthetJ , MorelI , FauconnierJ , et al. Antibiotic prophylaxis in cesarean sections without high risk of infection. Presse Medicale1990;19:1755‐8. ">Racinet 1990</a>). See <a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a> for details. </p> </section> </section> <section id="CD007482-sec-0082"> <h4 class="title">Excluded studies</h4> <p>Of those studies excluded from the analysis, some were because clinical outcomes for the women undergoing cesarean section were not reported separately or all women had received some form of antibiotic treatment and then were randomized to another intervention. For some studies, although the trial was initially randomized, part‐way through the study the placebo arm was dropped. Due to the results on the initially randomized part of the study not being available, these studies were not included (<i>See</i> table of <a href="./references#CD007482-sec-0129" title="">Characteristics of excluded studies</a> for further details). </p> </section> </section> <section id="CD007482-sec-0083"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodological quality of the trials was mostly unclear, explained in large part because the studies were undertaken a number of years ago, before the recent understanding of sources of bias in randomized controlled trials (<a href="#CD007482-fig-0001">Figure 1</a>; <a href="#CD007482-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD007482-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007482-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007482-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007482-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD007482-sec-0084"> <h4 class="title">Allocation</h4> <p>In less than 20% of studies, we judged there was a low risk of selection bias based on an adequate generation of a randomized sequence, such as referring to a random number table or "drawing lots". Most studies, however, did not describe the sequence generation process and were assessed as "unclear". Several studies where participants were allocated to treatment group by date of birth or hospital number were classified as quasi‐RCTs and judged at high risk of selection bias. </p> </section> <section id="CD007482-sec-0085"> <h4 class="title">Blinding</h4> <p>In almost a third of studies there was no blinding and the control group received no treatment. Performance bias and detection bias were judged as low when there was an adequate description of the steps taken to ensure blinding. However, although many studies were described as "double‐blind, placebo‐controlled", there was often insufficient information provided to be confident all members of the study team were blinded to allocation, that the outcome assessment was performed without knowledge of the treatment group, nor certainty that the blind could not be broken. The outcomes of wound infection and endometritis, which require clinical judgement, could be influenced by lack of blinding. </p> </section> <section id="CD007482-sec-0086"> <h4 class="title">Incomplete outcome data</h4> <p>In most studies, all women who were initially randomized were included in the outcomes and an intention‐to‐treat analysis was performed. Where dropouts were reported, insufficient data were usually provided for them to be included in an intention‐to‐treat analysis. Where the group allocation of dropouts was not provided, there was the possibility that there may have been selective withdrawals from one or other of the groups. There were some studies where a discrepancy in the numbers allocated to the randomized groups, unlikely to have occurred by chance, was not accounted for. In most cases the numbers in the placebo group were smaller than those in the treatment group, raising the possibility of selective withdrawals not mentioned in the published report. </p> </section> <section id="CD007482-sec-0087"> <h4 class="title">Selective reporting</h4> <p>We judged this as unclear for all studies as there were no study protocols available. However, it does appear for most of the studies that all the expected outcomes were included. </p> </section> <section id="CD007482-sec-0088"> <h4 class="title">Other potential sources of bias</h4> <p>We judged this as low for all studies as no other important sources of bias were identified.</p> </section> </section> <section id="CD007482-sec-0089"> <h3 class="title" id="CD007482-sec-0089">Effects of interventions</h3> <p>See: <a href="./full#CD007482-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotics versus no antibiotics for preventing infection after cesarean section</a>; <a href="./full#CD007482-tbl-0002"><b>Summary of findings 2</b> Antibiotics versus no antibiotics for preventing infection after elective cesarean section</a> </p> <section id="CD007482-sec-0090"> <h4 class="title">1. Antibiotic prophylaxis versus no prophylaxis (Analyses 1.1 to 1.7)</h4> <p>The overall findings were as follows:</p> <section id="CD007482-sec-0091"> <h5 class="title">Primary outcomes</h5> <p>There were reductions in all the maternal primary outcomes: febrile morbidity (average risk ratio (RR) 0.45; 95% confidence interval (CI) 0.40 to 0.51, 56 studies, 9046 women (Tau² = 0.07; Chi² = 89.58, df = 55 (P = 0.002); I² = 39% (<a href="./references#CD007482-fig-0007" title="">Analysis 1.1</a>); wound infection (RR 0.40; 95% CI 0.35 to 0.46, 82 studies, 14,407 women (Chi² = 102.56, df = 79 (P = 0.04); I² = 23% (<a href="./references#CD007482-fig-0008" title="">Analysis 1.2</a>); endometritis (RR 0.38; 95% CI 0.34 to 0.42), 83 studies, 13,548 women (Chi² = 90.59, df = 79 (P = 0.19); I² = 12% ( <a href="./references#CD007482-fig-0009" title="">Analysis 1.3</a>); and serious infectious morbidity (RR 0.31; 95% CI 0.20 to 0.49, 32 studies, 6159 women (Chi² = 14.26, df = 27 (P = 0.98); I² = 0% (<a href="./references#CD007482-fig-0010" title="">Analysis 1.4</a>).  </p> <p>There was no evidence of substantial heterogeneity amongst the studies contributing to each of the outcomes reported except for what we judged a moderate degree of heterogeneity amongst those studies reporting febrile morbidity. This could be explained by different criteria used in the studies to define fever/ febrile morbidity. See <a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a>. </p> <p>There were no data in any of the studies on the two infant primary outcomes of immediate adverse effects and infant thrush. </p> </section> <section id="CD007482-sec-0092"> <h5 class="title">Secondary outcomes</h5> <p>There were reductions in maternal urinary tract infection (RR 0.56; 95% CI 0.49 to 0.65, 66 studies, 10,928 women (<a href="./references#CD007482-fig-0011" title="">Analysis 1.5</a>) . Only 13 studies collected data on maternal adverse effects; more adverse events were observed in the treatment group (RR 2.43; 95% CI 1.00 to 5.90), 2131 women (<a href="./references#CD007482-fig-0012" title="">Analysis 1.6</a>). The most common side effect was rash, followed by phlebitis at the site of the intravenous infusion. There were no serious drug‐related adverse events reported. The difference in maternal length of stay in hospital (average mean difference (MD) ‐0.46, 95% CI ‐0.65 to ‐0.28), 3168 women (<a href="./references#CD007482-fig-0013" title="">Analysis 1.7</a>), reported in 19 studies was judged not clinically important. </p> <p>There were no data in any of the studies on the other secondary outcomes.</p> </section> <section id="CD007482-sec-0093"> <h5 class="title">Reporting bias</h5> <p>There was a potential for publication bias in the assessment of febrile morbidity, as judged by visual inspection of the funnel plot (<a href="#CD007482-fig-0003">Figure 3</a>); however, we estimated that any reporting bias was unlikely to influence the results because of the large number of participants in the symmetrical part of the plot. There was no funnel plot asymmetry for the other primary outcomes (<a href="#CD007482-fig-0004">Figure 4</a>; <a href="#CD007482-fig-0005">Figure 5</a>; <a href="#CD007482-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD007482-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.1 Maternal febrile morbidity/fever." data-id="CD007482-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.1 Maternal febrile morbidity/fever. </p> </div> </div> </div> <div class="figure" id="CD007482-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.2 Maternal wound infection." data-id="CD007482-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.2 Maternal wound infection. </p> </div> </div> </div> <div class="figure" id="CD007482-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.3 Maternal endometritis." data-id="CD007482-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.3 Maternal endometritis. </p> </div> </div> </div> <div class="figure" id="CD007482-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.4 Maternal serious infectious complications." data-id="CD007482-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.4 Maternal serious infectious complications. </p> </div> </div> </div> </section> <section id="CD007482-sec-0094"> <h5 class="title">Study quality</h5> <p>We undertook a sensitivity analysis on the primary outcomes by study quality, omitting the nine quasi‐RCTs (<a href="./references#CD007482-bbs2-0008" title="BilginT , OzanH , DirgenA , EsmerA . Comparison of four different antibiotics as prophylaxis in caesarean section. Journal of Obstetrics and Gynaecology1998;18(6):546‐7. ">Bilgin 1998</a>; <a href="./references#CD007482-bbs2-0023" title="FreemanGM . The efficacy of prophylactic antibiotics in high‐risk patients undergoing cesarean section. Journal of the American Osteopathic Association1982;81(9):610‐5. ">Freeman 1982</a>; <a href="./references#CD007482-bbs2-0039" title="HuamSH , LimJM , RamanS . Single‐dose antibiotic prophylaxis in women undergoing elective caesarean section. Medical Journal of Malaysia1997;52:3‐7. ">Huam 1997</a>; <a href="./references#CD007482-bbs2-0045" title="KellumRB , RobertsWE , HarrisJB , KhansurN , MorrisonJC . Effect of intrauterine antibiotic lavage after cesarean birth on postoperative morbidity. Journal of Reproductive Medicine1985;30:527‐9. ">Kellum 1985</a>; <a href="./references#CD007482-bbs2-0050" title="Lemus RochaR , Garcia GutierrezLB , Basavilvazo RodriguezMA , Cruz AvelarA , Peralta PedreroML , Hernandez ValenciaM . Incidence of infected surgical wound and prophylaxis with cefotaxime in cesarean section. Ginecologia y Obstetricia de Mexico2005;73(10):537‐43. ">Lemus 2005</a>; <a href="./references#CD007482-bbs2-0060" title="MorrisonJC , CoxwellWL , KennedyBS , SchreierPC , WiserWL , FishSA . The use of prophylactic antibiotics in patients undergoing cesarean section. Surgery, Gynecology and Obstetrics1973;136:425‐8. ">Morrison 1973</a>; <a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>; <a href="./references#CD007482-bbs2-0080" title="SokolowskiVH , CanzlerE , BrotzmannC . Influence of vagimid prophylaxis on course of puerperium and healing of the wound after caesarean section in comparison with a control group. Zentralblatt fur Gynakologie1989;111:461‐5. ">Sokolowski 1989</a>; <a href="./references#CD007482-bbs2-0085" title="TurnerMJ , EganDM , QureshiWA , SkehanM , BlackA , DarrellJH , et al. Use of cephradine prophylaxis of infection after caesarean section: stepwise logistic regression analysis of relevant factors. Journal of Obstetrics and Gynaecology1990;10:204‐9. ">Turner 1990</a>). The overall findings remained very similar with reductions for all the primary outcomes: febrile morbidity (average RR 0.47; 95% CI 0.41 to 0.53, 50 studies, 7852 women; wound infection (average RR 0.40; 95% CI 0.35 to 0.46, 76 studies, 12,669 women; endometritis (RR 0.39; 95% CI 0.35 to 0.43, 77 studies, 12,680 women). Serious infectious morbidity remained the same as the analysis contained no quasi‐RCTs. </p> </section> </section> <section id="CD007482-sec-0095"> <h4 class="title">2. Antibiotic prophylaxis versus no prophylaxis, subgroups by antibiotic regimen (Analyses 2.1 to 2.7) </h4> <p>There were no studies that reported on treatment with monotherapy with a penicillinase‐resistant penicillin, fourth generation cephalosporin, carbapenem, tetracycline, macrolide, and aminoglycosides. Approximately two thirds of studies evaluated treatment with a first or second generation cephalosporin, including cefamycins, or ampicillin. </p> <p>For all subgroups based on antibiotic regimen there were reductions in the maternal primary outcomes and maternal urinary tract infections. By inspection of the graphs visually there was no evidence of a clinically important difference by drug class. The interaction test did not suggest a difference between subgroups for the primary outcomes of wound infection (Chi² = 17.77; P = 0.17; I² = 26.8%), serious infectious outcomes (Chi² = 3.07; P = 0.93; I² = 0%) and urinary tract infection (Chi² = 16.3; P = 0.13; I² = 32.5%), however the interaction test did show a difference among subgroups for the primary outcomes of febrile morbidity (Chi² = 45.8; P &lt; 0.00001; I² = 73.8%) and endometritis (Chi² = 21.16; P = 0.07; I² = 38.6%). There was no evidence that a regimen with a broader spectrum of activity was any better than a drug with a narrow spectrum of activity or that any particular antibiotic regimen was ineffective. The largest risk reductions for wound infection were seen with the extended spectrum penicillin group (RR 0.18, 95% CI 0.09 to 0.39) and aminoglycoside containing regimens (RR 0.17 95% CI 0.08 to 0.34) (<a href="./references#CD007482-fig-0015" title="">Analysis 2.2</a>). For the first generation cephalosporins, the current recommended antibiotic for prophylaxis, the risk ratio for wound infection was 0.38 (95% CI 0.28 to 0.53) (<a href="./references#CD007482-fig-0015" title="">Analysis 2.2</a>). There was only one study that reported on lincomycin and no studies reported on clindamycin or a macrolide, which however are often given as an alternatives for prophylaxis in women who are allergic to penicillin. The reduction in the incidence of endometritis was similar amongst the different drug regimens (<a href="./references#CD007482-fig-0016" title="">Analysis 2.3</a>). The smallest reduction in endometritis was seen for beta lactamase inhibitor combinations (RR 0.67, 95% CI 0.27 to 1.66); for the first generation cephalosporins the relative risk was 0.42 (95% CI 0.33 to 0.54). Any comparison between regimens has, however, to be interpreted with caution given that the results are observational and not based on randomized comparisons. Please refer to the meta‐analysis of studies that compared different regimens (<a href="./references#CD007482-bbs2-0122" title="AlfirevicZ , GyteGM , DouL . Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD008726] ">Alfirevic 2010</a>). </p> </section> <section id="CD007482-sec-0096"> <h4 class="title">3. Antibiotic prophylaxis versus no prophylaxis, subgroups by type of cesarean section (Analyses 3.1 to 3.7) </h4> <p>In both elective and emergency cesarean sections as well as the "both or not defined" subgroup there was a reduction in febrile morbidity, wound infection, endometritis and urinary tract infection although there were insufficient data to assess any differential effect on serious infectious complications. For elective cesarean sections, the risk ratio for wound infections was 0.62, 95% CI 0.47 to 0.82 (<a href="./references#CD007482-fig-0022" title="">Analysis 3.2</a>) and for endometritis the RR was 0.38, 95% CI 0.24 to 0.61 (<a href="./references#CD007482-fig-0023" title="">Analysis 3.3</a>). We inspected the graphs visually and saw no difference in maternal febrile morbidity, wound infection or endometritis, among the three groups and as well the confidence intervals for the summary estimates overlapped, however, the interaction test did show a difference among subgroups for the outcome of wound infection (Chi² = 13.53; P = 0.001; I² = 85.2%) and maternal urinary tract infection ((Chi² = 6.42; P = 0.04; I² = 68.8%), but no difference for the outcomes of febrile morbidity (Chi² = 0.47; P = 0.79; I² = 0%), endometritis (Chi² = 0.36; P = 0.84; I² = 0%), or serious infectious outcome (Chi² = 0.62; P = 0.73; I² = 0%). </p> </section> <section id="CD007482-sec-0097"> <h4 class="title">4. Antibiotic prophylaxis versus no prophylaxis, subgroups by timing of administration (Analyses 4.1 to 4.7) </h4> <p>We inspected the graphs visually and found no difference in wound infection, endometritis or maternal urinary tract infection among the three groups and the confidence intervals for the summary estimates overlapped. As well, the interaction test did not suggest there was any real difference for the outcomes of wound infection (Chi² = 0.43; P = 0.81; I² = 0%), endometritis (Chi² = 3.74; P = 0.15; I² = 46.6%) and maternal urinary tract infection (Chi² = 2.07; P = 0.36; I² = 3.4%). However, the interaction test did suggest there was a difference among subgroups for the outcome of febrile morbidity (Chi² = 8.40; P = 0.01; I² = 76.2%). There was no difference among groups based on the interaction test for the outcome of serious maternal infectious complications (Chi² = 0.13; P = 0.94; I² = 0%), although there were insufficient data to conclude this with certainty. From these analyses there was no evidence that administering antibiotics before surgery was associated with a better outcome, but this conclusion needs to be interpreted with caution given that the results are observational and not based on randomized comparisons. </p> </section> <section id="CD007482-sec-0098"> <h4 class="title">Other considerations</h4> <section id="CD007482-sec-0099"> <h5 class="title">Infant</h5> <p>Infant outcomes were infrequently reported. No study reported on any long‐term adverse effects on the infant or effect of antibiotics on the infant immune system. In addition, no studies reported on the incidence of oral candidiasis (thrush) in babies, which we had categorized as an adverse outcome. </p> <p>Where Apgar scores were reported, there were no differences between the treatment and control groups (<a href="./references#CD007482-bbs2-0001" title="AdamI , AdamES , GeraisAS . Randomized trial of ceftriaxone prophylaxis in elective cesarean section. Saudi Medical Journal2005;26(3):500‐1. ">Adam 2005</a>; <a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0061" title="NgNK . The role of prophylactic antibiotics in caesarean section ‐ a randomized trial. Medical Journal of Malaysia1992;47:273‐9. ">Ng 1992</a>; <a href="./references#CD007482-bbs2-0073" title="RouziAA , KhalifaF , Ba'aqeelH , Al‐HamdanHS , BondagjiN . The routine use of cefazolin in cesarean section. International Journal of Gynecology and Obstetrics2000;69:107‐12. ">Rouzi 2000</a>). One study collected information on birthweight, number of days in hospital, admission to neonatal intensive care, early neonatal death, respiratory distress syndrome and neonatal sepsis and there was no difference between the treatment and control groups (<a href="./references#CD007482-bbs2-0073" title="RouziAA , KhalifaF , Ba'aqeelH , Al‐HamdanHS , BondagjiN . The routine use of cefazolin in cesarean section. International Journal of Gynecology and Obstetrics2000;69:107‐12. ">Rouzi 2000</a>) and another study reported that neonatal outcomes (respiratory distress syndrome, intracranial hemorrhage, necrotizing enterocolitis, sepsis and neonatal death) were not different among treatment groups (<a href="./references#CD007482-bbs2-0090" title="WittA , DonerM , PetricevicL , BergerA , GermannP , HeinzeG , et al. Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double‐blind, prospective, randomized, placebo‐controlled trial. Archives of Surgery2011;146(12):1404‐9. [PUBMED: 22184305] ">Witt 2011</a>). Some authors stated there were no complications in the babies due to drug administration, without further details (<a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0058" title="MoodleyJ , ZeemanDJ . Prophylactic and antimicrobial therapy using lincomycin in patients undergoing emergency caesarean section. South African Medical Journal1981;59:911‐3. ">Moodley 1981</a>) and that the administration of antibiotics did not interfere with routine pediatric cultures (<a href="./references#CD007482-bbs2-0025" title="GallSA . The efficacy of prophylactic antibiotics in caesarean section. American Journal of Obstetrics and Gynecology1979;134:506‐11. ">Gall 1979</a>) or the evaluation of newborn sepsis (<a href="./references#CD007482-bbs2-0018" title="DuffP , ParkRC . Antibiotic prophylaxis for cesarean section in a military population. Military Medicine (Washington DC)1980;145:377‐81. ">Duff 1980</a>). </p> <p>There were few neonatal deaths and where they were reported, no relationship to the administration of antibiotic was reported (<a href="./references#CD007482-bbs2-0001" title="AdamI , AdamES , GeraisAS . Randomized trial of ceftriaxone prophylaxis in elective cesarean section. Saudi Medical Journal2005;26(3):500‐1. ">Adam 2005</a>; <a href="./references#CD007482-bbs2-0016" title="DeBoerCN , ThorntonJG . Prophylactic short course rectal metronidazole for cesarean section. A double‐blind controlled trial of a simple low cost regimen. International Journal of Gynecology &amp; Obstetrics1989;28:103‐7. ">De Boer 1989</a>). </p> <p>Only one study reported on infant outcomes at four weeks and in that study the three infants who had complications were all in the control group (<a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>). </p> </section> <section id="CD007482-sec-0100"> <h5 class="title">Costs</h5> <p>Three studies reported post‐operative antibiotic costs. Drug costs were lower in the group receiving prophylaxis compared with the control group in one study (<a href="./references#CD007482-bbs2-0048" title="KristensenGB , BeiterEC , MatherO . Single‐dose cefuroxime prophylaxis in non‐elective cesarean section. Acta Obstetricia et Gynecologica Scandinavica1990;69:497‐500. ">Kristensen 1990</a>) but higher in the other two (<a href="./references#CD007482-bbs2-0007" title="BibiM , MegdicheH , GhanemH , SfaxiI , NouiraM , EssaidiH , et al. Antibiotic prophylaxis in a priori cesarean sections without a high risk of infection [L'antibioprophylaxie dans les cesariennes a priori sans 'haut risque infectieux']. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1994;23:451‐5. ">Bibi 1994</a>; <a href="./references#CD007482-bbs2-0066" title="MallaretMR , BlatierJF , RacinetC , FauconnierJ , FavierM , MicoudM . Economic benefit of using antibiotics prophylactically in cesarean sections with little risk of infection. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)1990;19:1061‐4. RacinetC , MallaretMR , FavierM , BerthetJ , MorelI , FauconnierJ , et al. Antibiotic prophylaxis in cesarean sections without high risk of infection. Presse Medicale1990;19:1755‐8. ">Racinet 1990</a>). <i>See</i><a href="./references#CD007482-sec-0128" title="">Characteristics of included studies</a> table for details of costs. </p> </section> <section id="CD007482-sec-0101"> <h5 class="title">Resistance</h5> <p>Changes in bacterial flora and the development of antibiotic resistant bacteria with the administration of antibiotics was not systematically collected in the studies included in this review, but several studies included detailed microbiological investigations, comparing the results of aerobic and anaerobic culture of the genital tract before and after the surgery and reporting on antimicrobial resistance in organisms associated with infection (<a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>; <a href="./references#CD007482-bbs2-0024" title="FugereP , TurgeonP , BoucherM , VerscheldenG , LemayM . Use of cephalosporins in antibiotic prophylaxis in women undergoing nonelective caesarean section [Utilisation des cephalosporines comme antibioprophylaxie lors de cesariennes]. Canadian Medical Association Journal1983;129:132‐5. ">Fugere 1983</a>; <a href="./references#CD007482-bbs2-0031" title="GibbsRS , StClairPJ , CastilloMS , CastanedaYS . Bacteriologic effects of antibiotic prophylaxis in high‐risk cesarean section. Obstetrics &amp; Gynecology1981;57:277‐82. ">Gibbs 1981</a>; <a href="./references#CD007482-bbs2-0036" title="HargerJH , EnglishDH . Selection of patients for antibiotic prophylaxis in cesarean sections. American Journal of Obstetrics and Gynecology1981;141:752‐8. ">Harger 1981</a>; <a href="./references#CD007482-bbs2-0040" title="IsmailMA , NelsonKE , LarsonP , MosesVK . Selective effect of cefoxitin prophylaxis on post‐cesarean‐section microbial flora. Journal of Reproductive Medicine1990;35:168‐74. ">Ismail 1990</a>; <a href="./references#CD007482-bbs2-0044" title="KarhunenM , KoskelaO , TeisalaK , SuikkariAM , MattilaJ . Prophylaxis and treatment of anaerobic infections following caesarean section with tinidazole. Chemotherapy1985;31:228‐36. ">Karhunen 1985</a>; <a href="./references#CD007482-bbs2-0047" title="KreutnerAK , DelBeneVE , DelamarD , HuguleyV , HarmonPM , MitchellKS . Perioperative antibiotic prophylaxis in cesarean section. Obstetrics &amp; Gynecology1978;52:279‐84. ">Kreutner 1978</a>; <a href="./references#CD007482-bbs2-0057" title="MillerRD , CrichtonD . Ampicillin prophylaxis in caesarean section. South African Journal of Obstetrics and Gynaecology1968;6:69‐70. ">Miller 1968</a>; <a href="./references#CD007482-bbs2-0059" title="MoroM , AndrewsM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1974;44:688‐92. ">Moro 1974</a>; <a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>; <a href="./references#CD007482-bbs2-0070" title="RoexAJM , PuyenbroekJI , MacLarenDM , VanGeijnHP , ArtsNFT . A randomized clinical trial of antibiotic prophylaxis in cesarean section: maternal morbidity, risk factors and bacteriological changes. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1986;22:117‐24. RoexAJM , PuyenbroekJI , MaclarenDM , ArtsNFTh . Short‐term antibiotic prophylaxis for caesarean section [Kortdurende antibioticum profylaxe bij de section Caesarea]. Nederland Tijdschrift voor Obstetrie en Gynaecologie1987;100:105. ">Roex 1986</a>; <a href="./references#CD007482-bbs2-0082" title="StiverHG , ForwardKR , LivingstoneRA , FugereP , LemayM , VerscheldenG , et al. Multicenter comparison of cefoxitin vs cefazolin for prevention of infectious morbidity after nonelective cesarean section. American Journal of Obstetrics and Gynecology1983;145:158‐63. StiverHG , ForwardKR , TyrrellDL , KripG , LivingstoneRA , FugereP , et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. American Journal of Obstetrics and Gynecology1984;149(7):718‐21. ">Stiver 1983</a>). </p> <p>There is a shift in the bacterial flora following the surgical procedure itself and return to the non‐pregnant state and even in the control groups more gram positive aerobic organisms (including staphylococcal species and enterococci) were observed post‐operatively (<a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>). Antibiotic prophylaxis was associated with increases in enterococci and gram‐negative aerobic organisms (<a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>; <a href="./references#CD007482-bbs2-0024" title="FugereP , TurgeonP , BoucherM , VerscheldenG , LemayM . Use of cephalosporins in antibiotic prophylaxis in women undergoing nonelective caesarean section [Utilisation des cephalosporines comme antibioprophylaxie lors de cesariennes]. Canadian Medical Association Journal1983;129:132‐5. ">Fugere 1983</a>; <a href="./references#CD007482-bbs2-0031" title="GibbsRS , StClairPJ , CastilloMS , CastanedaYS . Bacteriologic effects of antibiotic prophylaxis in high‐risk cesarean section. Obstetrics &amp; Gynecology1981;57:277‐82. ">Gibbs 1981</a>; <a href="./references#CD007482-bbs2-0047" title="KreutnerAK , DelBeneVE , DelamarD , HuguleyV , HarmonPM , MitchellKS . Perioperative antibiotic prophylaxis in cesarean section. Obstetrics &amp; Gynecology1978;52:279‐84. ">Kreutner 1978</a>); cefazolin was associated with more anaerobic isolates (<a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>; <a href="./references#CD007482-bbs2-0024" title="FugereP , TurgeonP , BoucherM , VerscheldenG , LemayM . Use of cephalosporins in antibiotic prophylaxis in women undergoing nonelective caesarean section [Utilisation des cephalosporines comme antibioprophylaxie lors de cesariennes]. Canadian Medical Association Journal1983;129:132‐5. ">Fugere 1983</a>; <a href="./references#CD007482-bbs2-0047" title="KreutnerAK , DelBeneVE , DelamarD , HuguleyV , HarmonPM , MitchellKS . Perioperative antibiotic prophylaxis in cesarean section. Obstetrics &amp; Gynecology1978;52:279‐84. ">Kreutner 1978</a>) and cefoxitin and cefamandole with a decrease in anaerobic isolates (<a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>; <a href="./references#CD007482-bbs2-0031" title="GibbsRS , StClairPJ , CastilloMS , CastanedaYS . Bacteriologic effects of antibiotic prophylaxis in high‐risk cesarean section. Obstetrics &amp; Gynecology1981;57:277‐82. ">Gibbs 1981</a>). </p> <p>Given that most regimens included a cephalosporin which has no activity against enterococci, it is not surprising that most studies reported significant increases in enterococcal colonization (<a href="./references#CD007482-bbs2-0031" title="GibbsRS , StClairPJ , CastilloMS , CastanedaYS . Bacteriologic effects of antibiotic prophylaxis in high‐risk cesarean section. Obstetrics &amp; Gynecology1981;57:277‐82. ">Gibbs 1981</a>; <a href="./references#CD007482-bbs2-0040" title="IsmailMA , NelsonKE , LarsonP , MosesVK . Selective effect of cefoxitin prophylaxis on post‐cesarean‐section microbial flora. Journal of Reproductive Medicine1990;35:168‐74. ">Ismail 1990</a>; <a href="./references#CD007482-bbs2-0082" title="StiverHG , ForwardKR , LivingstoneRA , FugereP , LemayM , VerscheldenG , et al. Multicenter comparison of cefoxitin vs cefazolin for prevention of infectious morbidity after nonelective cesarean section. American Journal of Obstetrics and Gynecology1983;145:158‐63. StiverHG , ForwardKR , TyrrellDL , KripG , LivingstoneRA , FugereP , et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. American Journal of Obstetrics and Gynecology1984;149(7):718‐21. ">Stiver 1983</a>). Harger reported that the isolates from infected sites in cefoxitin infected women showed a relative predominance of enterococci (<a href="./references#CD007482-bbs2-0036" title="HargerJH , EnglishDH . Selection of patients for antibiotic prophylaxis in cesarean sections. American Journal of Obstetrics and Gynecology1981;141:752‐8. ">Harger 1981</a>). Ismail reported that enterococcal sepsis occurred in one patient and three others had significant enterococcal bacteriuria or urinary tract infection (<a href="./references#CD007482-bbs2-0040" title="IsmailMA , NelsonKE , LarsonP , MosesVK . Selective effect of cefoxitin prophylaxis on post‐cesarean‐section microbial flora. Journal of Reproductive Medicine1990;35:168‐74. ">Ismail 1990</a>). </p> <p>There were very few reports of resistant organisms developing following prophylaxis. No cefoxitin resistant strains of Enterobacteriaceae were isolated from stool samples after prophylaxis (<a href="./references#CD007482-bbs2-0040" title="IsmailMA , NelsonKE , LarsonP , MosesVK . Selective effect of cefoxitin prophylaxis on post‐cesarean‐section microbial flora. Journal of Reproductive Medicine1990;35:168‐74. ">Ismail 1990</a>). In one study, there were more ampicillin resistant urinary tract infections when ampicillin was used for prophylaxis compared with control (9/17 versus 8/26) (<a href="./references#CD007482-bbs2-0057" title="MillerRD , CrichtonD . Ampicillin prophylaxis in caesarean section. South African Journal of Obstetrics and Gynaecology1968;6:69‐70. ">Miller 1968</a>). Rothbard reported one infection with an organism resistant to cephalothin and kanamycin used for prophylaxis (<a href="./references#CD007482-bbs2-0072" title="RothbardMJ , MayerW , WystepekA , GordonM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1975;45:421‐4. ">Rothbard 1975</a>) and Duff reported an endometrial culture that grew <i>Klebsiella pneumoniae</i> resistant to ampicillin (<a href="./references#CD007482-bbs2-0018" title="DuffP , ParkRC . Antibiotic prophylaxis for cesarean section in a military population. Military Medicine (Washington DC)1980;145:377‐81. ">Duff 1980</a>). Engel reported urinary tract infections with mezlocillin resistant organisms (5/9) after mezlocillin prophylaxis and observed colonization with mezlocillin resistant strains of <i>E. coli</i> in cultures from the cervix (<a href="./references#CD007482-bbs2-0021" title="EngelK , Amir‐MoazamiB , KarschniaR , HahnT . Advantages and hazards of preventing infection following cesarean section‐‐clinical and bacteriologic results of a high‐dosage treatment with mezlocillin and oxacillin short‐term preventive following clamping of the umbilical cord [Nutzen und Gefahren der Infektionsprophylaxe bei der Sectio caesarea‐‐klinische und bakteriologische Ergebnisse einer hochdosierten Kurzzeitprophylaxe nach dem Abnabeln mit Mezlocillin und Oxacillin.]. Geburtshilfe und Frauenheilkunde1984;44(3):162‐70. EngelK , KarschniaR . Bacterial flora changes resulting from antimicrobial treatment. Journal of Obstetrics and Gynaecology1986;6:6‐8. ">Engel 1984</a>). In one study of cephalothin, all the organisms causing infection in the antibiotic group were described as sensitive to cephalothin <i>in vitro</i> (<a href="./references#CD007482-bbs2-0059" title="MoroM , AndrewsM . Prophylactic antibiotics in cesarean section. Obstetrics &amp; Gynecology1974;44:688‐92. ">Moro 1974</a>). In a study of cefoxitin prophylaxis, it was observed that the changes in endogenous flora were not associated with overgrowth of resistant pathogens, such as <i>Pseudomonas</i> , enterococci or <i>Enterobacter</i> (<a href="./references#CD007482-bbs2-0070" title="RoexAJM , PuyenbroekJI , MacLarenDM , VanGeijnHP , ArtsNFT . A randomized clinical trial of antibiotic prophylaxis in cesarean section: maternal morbidity, risk factors and bacteriological changes. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1986;22:117‐24. RoexAJM , PuyenbroekJI , MaclarenDM , ArtsNFTh . Short‐term antibiotic prophylaxis for caesarean section [Kortdurende antibioticum profylaxe bij de section Caesarea]. Nederland Tijdschrift voor Obstetrie en Gynaecologie1987;100:105. ">Roex 1986</a>) and Karhunen reported no superinfections with resistant anaerobic organisms when tinidazole was used for prophylaxis (<a href="./references#CD007482-bbs2-0044" title="KarhunenM , KoskelaO , TeisalaK , SuikkariAM , MattilaJ . Prophylaxis and treatment of anaerobic infections following caesarean section with tinidazole. Chemotherapy1985;31:228‐36. ">Karhunen 1985</a>). Stiver confirmed that there was no increase in nosocomial infection (<a href="./references#CD007482-bbs2-0082" title="StiverHG , ForwardKR , LivingstoneRA , FugereP , LemayM , VerscheldenG , et al. Multicenter comparison of cefoxitin vs cefazolin for prevention of infectious morbidity after nonelective cesarean section. American Journal of Obstetrics and Gynecology1983;145:158‐63. StiverHG , ForwardKR , TyrrellDL , KripG , LivingstoneRA , FugereP , et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. American Journal of Obstetrics and Gynecology1984;149(7):718‐21. ">Stiver 1983</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007482-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007482-sec-0102"></div> <section id="CD007482-sec-0103"> <h3 class="title" id="CD007482-sec-0103">Summary of main results</h3> <p>This review included 95 studies that evaluated the effect of antibiotics for preventing infection after cesarean section in over 15,000 women. Compared with placebo or no treatment, the use of prophylactic antibiotics in women undergoing cesarean section reduced the incidence of wound infection and endometritis by around 60% and serious maternal infectious complications were reduced by 70%. See <a href="./full#CD007482-tbl-0001">summary of findings Table for the main comparison</a>. When only studies that included women undergoing an elective cesarean section were analyzed, wound infections were reduced by 40% and endometritis by 60%. See <a href="./full#CD007482-tbl-0002">summary of findings Table 2</a>. Similar estimates of effect were seen whether the antibiotics were administered before the cord was clamped or after. </p> <p>There were no data on which to estimate the effect of maternal administration of antibiotics on infant outcomes. No studies systematically collected and reported on adverse infant outcomes nor the effect of antibiotics on the developing infant immune system. No studies reported on the incidence of oral candidiasis (thrush) in babies. Maternal adverse effects were also rarely described. </p> <p>The effect of different antibiotic regimens was studied and similar reductions in the incidence of infections seen for most of the antibiotics and combinations studied. </p> <p>Febrile morbidity is common after cesarean section and, although not judged a clinically important outcome, it was reduced with the use of prophylactic antibiotics. Few of these women will have positive bacterial cultures or a specific indication for antimicrobial treatment, but these women often have specimens collected and empiric antibiotic therapy started. There was a similar reduction in the incidence of urinary tract infections. </p> </section> <section id="CD007482-sec-0104"> <h3 class="title" id="CD007482-sec-0104">Overall completeness and applicability of evidence</h3> <p>These studies enrolled over 15,000 women extending over a period of more than 40 years, but only seven studies were reported since 2000. The studies varied in setting (both low‐income and high‐income countries), antibiotic regimen, risk of infection and definitions of outcomes, but we did not find evidence of statistically important heterogeneity in the measurement of effect among the studies. The reductions in infection seen are clinically important. The results of these studies have been generalized to the whole population of women undergoing cesarean section and based on the steady accumulation of evidence have been incorporated into all recent guidelines (<a href="./references#CD007482-bbs2-0121" title="American College of Obstetricians and Gynecologists. ACOG practice bulletin number 120, Prophylactic antibiotics in labor and delivery. Obstetrics &amp; Gynecology2011;117(6):1472‐83. ">ACOG 2011</a>; <a href="./references#CD007482-bbs2-0162" title="National Institute for Health and Clinical Excellence. Caesarean Section. NICE Clinical Guideline 132. NICE, 2011. ">NICE 2011</a>; <a href="./references#CD007482-bbs2-0172" title="vanSchalkwykJ , VanEykN , for the Society of Obstetricians and Gynaecologists of Canada Infectious Diseases Committee. Antibiotic prophylaxis in obstetric procedures. Journal of Obstetrics and Gynaecology of Canada: JOGC2010;32(9):879‐85. ">SOGC 2010</a>). </p> <p>Inconsistent adherence to policies for administering antibiotic prophylaxis are reported (<a href="./references#CD007482-bbs2-0151" title="HuskinsWC , Ba‐ThikeK , FestinMR , LimpongsanurakS , LumbiganonP , PeedicayilA , et al. An international survey of practice variation in the use of antibiotic prophylaxis in cesarean section. International Journal of Gynecology &amp; Obstetrics2001;73(2):141‐5. ">Huskins 2001</a>; <a href="./references#CD007482-bbs2-0157" title="MahMW , PyperAM , OniGA , MemishZA . Impact of antibiotic prophylaxis on wound infection after cesarean section in a situation of expected high risk. American Journal of Infection Control2001;29(2):85‐8. ">Mah 2001</a>; <a href="./references#CD007482-bbs2-0167" title="PedersenTK , BlaakaerJ . Antibiotic prophylaxis in cesarean section. Acta Obstetricia et Gynecologica Scandinavica1996;75:537‐9. ">Pedersen 1996</a>) but simple quality improvement methods have been demonstrated to improve adherence with overall and timely administration of prophylaxis and reduce the infection rate (<a href="./references#CD007482-bbs2-0182" title="WeinbergM , FuentesJM , RuizAI , LozanoFW , AngelE , GaitanH , et al. Reducing infections among women undergoing cesarean section in Columbia by means of continuous quality improvement methods. Archives of Internal Medicine2001;161:2357‐65. ">Weinberg 2001</a>). It was also shown, in this study (<a href="./references#CD007482-bbs2-0182" title="WeinbergM , FuentesJM , RuizAI , LozanoFW , AngelE , GaitanH , et al. Reducing infections among women undergoing cesarean section in Columbia by means of continuous quality improvement methods. Archives of Internal Medicine2001;161:2357‐65. ">Weinberg 2001</a>) that a program that introduced a policy of universal prophylaxis for all women undergoing a cesarean section was more effective than one that required the obstetrician to decide whether a woman was high risk and mandated prophylaxis only for the high‐risk women. </p> <p>A statistically significant reduction in all the primary outcomes (febrile morbidity, wound infection, endometritis, serious maternal outcomes) was seen whether the antibiotic was administered before the clamping of the cord or after clamping of the cord. There was no significant difference in the estimates for these outcomes by the timing of administration and the confidence intervals were overlapping. It has, however, been shown that the lowest risk of surgical wound infection is associated with antibiotics administered in the pre‐operative period as compared with the perioperative or post‐operative period (<a href="./references#CD007482-bbs2-0130" title="ClassenDC , EvansRS , PestotnikSL , HornSD , MenloveRL , BurkeJP . The timing of prophylactic administration of antibiotics and the risk of surgical‐wound infection. New England Journal of Medicine1992;326(5):281‐6. ">Classen 1992</a>). Although studies have not show an increase in infectious outcomes when the antibiotic was administered after the cord was clamped (<a href="./references#CD007482-bbs2-0132" title="CunninghamFG , LevenoKJ , DePalmaRT , RoarkM , RosenfeldCR . Perioperative antimicrobials for cesarean delivery: before or after cord clamping. Obstetrics &amp; Gynecology1983;62(2):151‐4. ">Cunningham 1983</a>; <a href="./references#CD007482-bbs2-0032" title="GordonHR , PhelpsD , BlanchardK . Prophylactic cesarean section antibiotics: maternal and neonatal morbidity before or after cord clamping. Obstetrics &amp; Gynecology1979;53:151‐6. ">Gordon 1979</a>; <a href="./references#CD007482-bbs2-0180" title="WaxJR , HerseyK , PhilputC , WrightMS , NicholsKV , EgglestonMK , et al. Single dose cefazolin prophylaxis for postcesarean infections: before vs after cord clamping. Journal of Maternal Fetal Medicine1997;6(1):61‐5. ">Wax 1997</a>), meta‐analyses of randomized controlled trials concluded that there was strong evidence that antibiotic prophylaxis given before skin incision decreased the incidence of postpartum endometritis and total infectious morbidities compared with after the cord was clamped (<a href="./references#CD007482-bbs2-0123" title="BaaqeelH , BaaqeelR . Timing of administration of prophylactic antibiotics for caesarean section: a systematic review and meta‐analysis. BJOG: an international journal of obstetrics and gynaecology2013;120(6):661‐9. [DOI: 10.1111/1471‐0528.12036] ">Baaqeel 2013</a>; <a href="./references#CD007482-bbs2-0131" title="CostantineMM , RahmanM , GhulmiyahL , ByersBD , LongoM , WenT , et al. Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. American Journal of Obstetrics and Gynecology2008;199(3):301.e1‐6. ">Costantine 2008</a>). Pre‐operative administration of antibiotics did not significantly affect proven neonatal sepsis, suspected sepsis or neonatal intensive care unit admissions. In a retrospective study on the effect of a change in policy to administer prophylactic antibiotics before skin incision, the overall rate of surgical site infections fell from 6.2% to 2.5% (<a href="./references#CD007482-bbs2-0152" title="KaimalAJ , ZlatnikMG , ChengYW , ThietMP , ConnattyE , CreedyP , et al. Effect of a change in policy regarding the timing of prophylactic antibiotics on the rate of postcesarean delivery surgical‐site infections. American Journal of Obstetrics and Gynecology2008;199(3):310. e1‐5. ">Kaimal 2008</a>). </p> <section id="CD007482-sec-0105"> <h4 class="title">Adverse effects</h4> <p>Maternal side effects were not consistently collected nor reported. Generally the side effects of a single antibiotic dose are mild, but rarely serious allergic reactions can occur. Although the risk of side effects reported in these studies was low, these data were incompletely collected, making it difficult to know accurately the incidence of the adverse effects of treatment and truly judge the benefits and harms of the intervention. </p> <p>Infant outcomes were rarely systematically collected but when they were reported there was no evidence of any adverse effects associated with the administration of antibiotic. There is evidence that antibiotics given near or shortly after birth can affect the infant gut flora, with the potential to impact mucosal and systemic immune function (<a href="./references#CD007482-bbs2-0126" title="Bedford RussellA , MurchS . Could peripartum antibiotics have delayed health consequences for the infant?. BJOG: an international journal of obstetrics and gynaecology2006;113:758‐65. ">Bedford Russell 2006</a>) but no study has prospectively examined the effect of any changes in flora on these or other outcomes. Oral yeast infection (thrush) was not an outcome reported in any of the included studies. </p> <p>There are also unknown and unquantified effects of antibiotic use that include changing the normal maternal flora, effects on the presentation of infection in the infant, and the development of antimicrobial resistance. There are changes in bacterial flora with the administration of antibiotics, with an increase in enterococcal colonization and evidence of the development of antibiotic resistant bacteria but few incidences where this was associated with infectious complications (<a href="./references#CD007482-bbs2-0140" title="GalaskRP . Changing concepts in obstetric antibiotic prophylaxis. American Journal of Obstetrics and Gynecology1987;157(2):491‐7. ">Galask 1987</a>). In women who developed endometritis, prophylaxis with ampicillin or cefazolin alters the genital tract microflora, but this had no effect on cure rates (<a href="./references#CD007482-bbs2-0161" title="Newton , ER , WallacePA . Effects of prophylactic antibiotics on endometrial flora in women with postcesarean endometritis. Obstettocs and Gynecology1998;92(2):262‐8. ">Newton 1998</a>) </p> <p>While increased use of antimicrobial prophylaxis may be one factor in increasing antimicrobial resistance (<a href="./references#CD007482-bbs2-0171" title="ShlaesDM , GerdingDN , JohnJJ , CraigWA , BornsteinDL , DuncanRA , et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance in hospitals. Clinical Infectious Diseases1997;25:584‐99. ">Shlaes 1997</a>), there are no data supporting the contention that appropriate use of short course antimicrobial prophylaxis will cause significant bacterial resistance nor evidence that a policy of antibiotic prophylaxis for cesarean section has harmful effects that outweigh its benefits, even in those women perceived to be at low risk. Optimizing the choice and the duration of prophylactic antibiotic therapy is recommended as one strategy to prevent antimicrobial resistance (<a href="./references#CD007482-bbs2-0171" title="ShlaesDM , GerdingDN , JohnJJ , CraigWA , BornsteinDL , DuncanRA , et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance in hospitals. Clinical Infectious Diseases1997;25:584‐99. ">Shlaes 1997</a>). Trends in antibiotic resistance should be monitored, reported and used to establish practice guidelines and monitor institutional policies. Susceptibility testing of significant bacterial isolates should guide antimicrobial therapy of individual women who develop infection despite prophylaxis. </p> </section> </section> <section id="CD007482-sec-0106"> <h3 class="title" id="CD007482-sec-0106">Quality of the evidence</h3> <p>We used the GRADE approach to assess the quality for the evidence. We judged the evidence for antibiotic treatment compared with no treatment to be of moderate quality, meaning that further research would likely change our confidence in the result and the size of the estimate of the effect. Many of the included trials were more than 15 years old and lacked an adequate description of methods to allow a judgement on the risk of bias and for several studies there was clearly a high risk of bias. </p> </section> <section id="CD007482-sec-0107"> <h3 class="title" id="CD007482-sec-0107">Potential biases in the review process</h3> <p>We followed a well‐characterized search strategy to identify relevant trials, including non‐English language papers, but recognize that some trials may not have been available on‐line, especially older studies performed before the availability of electronic databases. We were unable to contact most of the authors where we needed clarification of information because there were no up‐to‐date contact details and for foreign‐language studies we relied on a translated copy, which was sometimes incomplete. </p> </section> <section id="CD007482-sec-0108"> <h3 class="title" id="CD007482-sec-0108">Agreements and disagreements with other studies or reviews</h3> <p>This review included in its definition of an elective cesarean section those women not in labor but with ruptured membranes for less than six hours, included studies that did not have a placebo arm and included studies that used antibiotic irrigation as well as systemic agents. A meta‐analysis (<a href="./references#CD007482-bbs2-0129" title="ChelmowD , RueehliMS , HuangE . Prophylactic use of antibiotics for nonlaboring patients undergoing cesarean delivery with intact membranes: a meta‐analysis. American Journal of Obstetrics and Gynecology2001;184(4):656‐61. ">Chelmow 2001</a>) that used an expanded search strategy to identify additional relevant studies, and included only placebo‐controlled studies of systemic antibiotics in women undergoing elective cesarean section who were non‐laboring with intact membranes, showed a reduction in infections in this low‐risk population and supports the conclusion of this review. In a prospective cohort study from a high‐risk obstetrical unit in New York state, absence of antibiotic prophylaxis was identified by multiple logistic regression analysis as being independently associated with surgical site infection after cesarean section for both high‐risk women and low‐risk women and was identified as one of the modifiable factors (<a href="./references#CD007482-bbs2-0153" title="KillianCA , GraffunderEM , VinciguerraTJ , VeneziaRA . Risk factors for surgical‐site infections following cesarean section. Infection Control and Hospital Epidemiology2001;22:613‐7. ">Killian 2001</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007482-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD007482-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD007482-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.1 Maternal febrile morbidity/fever." data-id="CD007482-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.1 Maternal febrile morbidity/fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.2 Maternal wound infection." data-id="CD007482-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.2 Maternal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.3 Maternal endometritis." data-id="CD007482-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.3 Maternal endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.4 Maternal serious infectious complications." data-id="CD007482-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Antibiotic versus no antibiotics, outcome: 1.4 Maternal serious infectious complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 1 Maternal febrile morbidity/fever." data-id="CD007482-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 1 Maternal febrile morbidity/fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 2 Maternal wound infection." data-id="CD007482-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 2 Maternal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 3 Maternal endometritis." data-id="CD007482-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 3 Maternal endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 4 Maternal serious infectious complications." data-id="CD007482-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 4 Maternal serious infectious complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 5 Maternal urinary tract infection." data-id="CD007482-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 5 Maternal urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 6 Maternal adverse effects." data-id="CD007482-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 6 Maternal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic versus no antibiotics, Outcome 7 Maternal days in hospital." data-id="CD007482-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic versus no antibiotics, Outcome 7 Maternal days in hospital.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 1 Maternal febrile morbidity/fever." data-id="CD007482-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 1 Maternal febrile morbidity/fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 2 Maternal wound infection." data-id="CD007482-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 2 Maternal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 3 Maternal endometritis." data-id="CD007482-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 3 Maternal endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 4 Maternal serious infectious complications." data-id="CD007482-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 4 Maternal serious infectious complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 5 Maternal urinary tract infection." data-id="CD007482-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 5 Maternal urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 6 Maternal adverse effects." data-id="CD007482-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 6 Maternal adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 7 Maternal days in hospital." data-id="CD007482-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic, Outcome 7 Maternal days in hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 1 Maternal febrile morbidity/fever." data-id="CD007482-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 1 Maternal febrile morbidity/fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 2 Maternal wound infection." data-id="CD007482-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 2 Maternal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 3 Maternal endometritis." data-id="CD007482-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 3 Maternal endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 4 Maternal serious infectious complications." data-id="CD007482-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 4 Maternal serious infectious complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 5 Maternal urinary tract infection." data-id="CD007482-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 5 Maternal urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 6 Maternal adverse effects." data-id="CD007482-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 6 Maternal adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 7 Maternal days in hospital." data-id="CD007482-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section, Outcome 7 Maternal days in hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 1 Maternal febrile morbidity/fever." data-id="CD007482-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 1 Maternal febrile morbidity/fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 2 Maternal wound infection." data-id="CD007482-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 2 Maternal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 3 Maternal endometritis." data-id="CD007482-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 3 Maternal endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 4 Maternal serious infectious complications." data-id="CD007482-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 4 Maternal serious infectious complications. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 5 Maternal urinary tract infections." data-id="CD007482-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 5 Maternal urinary tract infections. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 6 Maternal adverse effects." data-id="CD007482-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 6 Maternal adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007482-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/urn:x-wiley:14651858:media:CD007482:CD007482-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_t/tCD007482-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 7 Maternal days in hospital." data-id="CD007482-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Antibiotics versus no antibiotics ‐ subgroup by timing of administration, Outcome 7 Maternal days in hospital. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/media/CDSR/CD007482/image_n/nCD007482-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007482-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics versus no antibiotics for preventing infection after cesarean section</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics versus no antibiotics for preventing infection after cesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> Women undergoing cesarean section.<br/> <b>Settings:</b> Both high‐ and low‐income countries.<br/> <b>Intervention:</b> Antibiotic prophylaxis<sup>1</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antibiotic prophylaxis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Maternal wound infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low (elective)<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.40</b> <br/> (0.35 to 0.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>14407<br/> (82 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> <br/> (24 to 31) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Median<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>89 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> <br/> (31 to 41) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Other (includes emergency)<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b> <br/> (34 to 45) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>Maternal endometritis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Low (elective)<sup>2</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p><b>RR 0.38</b> <br/> (0.34 to 0.42) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>13548<br/> (83 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (13 to 16) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Median<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>160 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> <br/> (54 to 67) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Other (includes emergency)<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>184 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> <br/> (63 to 77) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal serious infectious complications</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>25 per 1000</b><sup>4</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8 per 1000</b> <br/> (5 to 12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.31</b> <br/> (0.2 to 0.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6159<br/> (32 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects on infant</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infant outcomes were not systematically collected nor reported. <sup>6</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> All classes of antibiotics, dosing regimens (both before and after clamping of the cord) and routes of administration were included.<br/> <sup>2</sup> The low risk baseline value is the mean of the control groups of studies reporting outcomes for elective cesarean sections; the other risk estimate is derived from the remaining studies in the review and includes emergency cesarean sections and studies which did not meet our criteria for elective.The median value from all studies is also reported.<br/> <sup>3</sup> In most studies the assessment of bias was judged as unclear. In a third of studies the control group did not receive a placebo and lack of blinding could have influenced the assessment of outcomes. In less than 20% of studies was there an adequate description of sequence generation.<br/> <sup>4</sup> The study population baseline risk is the mean value in the control groups from all studies that reported this outcome.<br/> <sup>5</sup> There was no consistent approach to the definition of serious infectious complications; in only 32 studies was this outcome reported.<br/> <sup>6</sup> No study reported effects of antibiotics on the infant immune system or outcome of oral thrush. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics versus no antibiotics for preventing infection after cesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007482-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotics versus no antibiotics for preventing infection after elective cesarean section</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics versus no antibiotics for preventing infection after elective cesarean section</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> Women undergoing elective cesarean section<br/> <b>Settings:</b> Both high‐ and low‐income countries<br/> <b>Intervention:</b> Antibiotic prophylaxis </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Antibiotic prophylaxis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal wound infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b> <br/> (32 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.62</b> <br/> (0.47 to 0.82) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3537<br/> (17 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal endometritis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>39 per 1000</b><sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (9 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.38</b> <br/> (0.24 to 0.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2502<br/> (15 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Maternal serious infectious complications</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.01</b> <br/> (0.04 to 24.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>545<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was only one adverse event reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects on infant</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infant outcomes were very infrequently reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> The study population baseline risk is the mean value in the control groups from all studies that included women undergoing elective cesarean section.<br/> <sup>2</sup> In most studies the assessment of bias was judged as unclear.<br/> <sup>3</sup> There was only one serious infectious complication reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotics versus no antibiotics for preventing infection after elective cesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007482-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Classification of antibiotics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Penicillinase‐resistant penicillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cloxacillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Extended spectrum of activity compared with natural penicillin</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aminopenicillins</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ampicillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extended‐spectrum penicillins</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ticarcillin, pipericillin, carbenicillin, mezlocillin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Beta‐lactamase inhibitor combination</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sulbactam</p> <p>Augmentin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cephalosporins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1st generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cefazolin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2nd generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cefamandole, cefuroxime</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cefamycins (2nd generation)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cefoxitin, cefotetan</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3rd generation</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4th generation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Carbapenems and monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tetracyclines</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Macrolides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aminoglycosides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gentamicin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clindamycin, lincomycin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nitroimidazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Metronidazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aminoglycoside containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Other regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Classification of antibiotics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/full#CD007482-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007482-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic versus no antibiotics</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal febrile morbidity/fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9046</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.40, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.35, 0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Maternal endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13548</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.34, 0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal serious infectious complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.20, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10928</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.49, 0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.43 [1.00, 5.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal days in hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.65, ‐0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic versus no antibiotics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007482-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal febrile morbidity/fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Aminopenicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.26, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Extended spectrum penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.28, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Beta‐lactamase inhibitor combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>791</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.29, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 First generation cephalosporins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.44, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Second generation cephalosporins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.27, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1894</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.61, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Third generation cephalosporins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.27, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.29, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.08, 3.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1098</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.48, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14 Aminoglycoside‐containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.24, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>530</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.17, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.07, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.07, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Aminopenicillins (ampicillin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.35, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Extended spectrum penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>845</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.09, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Beta‐lactamase inhibitor combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.13, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 First generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.28, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Second generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.19, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2635</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.33, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8 Third generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.26, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 5.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.34, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14 Aminoglycoside‐containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.08, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>530</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.36, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.15, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Maternal endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.05, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Aminopenicillins (ampicillin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.16, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Extended‐spectrum penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.37, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Beta‐lactamase inhibitor combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>788</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.27, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 First generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.33, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Second generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.20, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.28, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8 Third generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.11, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.25, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>919</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.37, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.13 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.20, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.14 Aminoglycoside‐containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>722</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.19, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.15 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>530</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.14, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.17, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal serious infectious complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Aminopenicillins (ampicillin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>542</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.06, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Extended‐spectrum penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.05, 5.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Beta‐lactamase inhibitor combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5 First generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.16, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.6 Second generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>522</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.06, 2.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.10, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8 Third generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.12, 4.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.06, 25.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>516</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.13, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.13 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.14 Aminoglycoside‐containing regimens</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.06, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.15 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Aminopenicillins (ampicillin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1039</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.41, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Extended‐spectrum penicillin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.20, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Beta‐lactamse inhibitor combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>788</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.41, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 First generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.49, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Second generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.38, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.54, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8 Third generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>308</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.04, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.35, 5.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.53, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.13 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.14 Aminoglycoside‐containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.15, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.15 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.32, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.02, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Aminopenisillins (ampicillin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Extended‐spectrum penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.96 [0.12, 71.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Beta‐lactamase inhibitor combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 First generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>507</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.15, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Second generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.07, 36.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>654</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.96 [0.41, 9.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8 Third generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.94 [0.12, 70.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.13 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.14 Amimnoglycoside‐containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 71.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.15 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal days in hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Natural penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Aminopenicillins (ampicillin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>191</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.82 [‐1.33, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Extended‐spectrum penicillins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Beta‐lactamase inhibitor combinations</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.46, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 First generation cephalosporins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.58, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 Second generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.69, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7 Cefamycins</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.60, ‐0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.8 Third generation cephalosporin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.9 Monobactams</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.10 Lincosamides</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.11 Nitroimidazoles</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.91 [‐1.37, ‐0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.12 Fluoroquinolones</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.13 Aminoglycoside‐containing combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.14 Other antibiotic combination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.15 Trimethoprim‐sulfamethoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.16 Other regimen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Antibiotic versus no antibiotic ‐ subgroup by class of antibiotic</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007482-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal febrile morbidity/fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.38, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.37, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4725</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.40, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.47, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.27, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8579</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.28, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Maternal endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.24, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.33, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.32, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal serious infectious complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>545</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.04, 24.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>696</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.12, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.19, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.57, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1981</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.31, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7043</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.49, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>808</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.86 [0.61, 13.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1088</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.23 [0.75, 6.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal days in hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1065</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐0.62, ‐0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Non‐elective cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.46 [‐0.78, ‐0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Both elective and non‐elective, or undefined cesarean section</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.39 [‐0.57, ‐0.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Antibiotics versus no antibiotics ‐ subgroup by type of cesarean section</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007482-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antibiotics versus no antibiotics ‐ subgroup by timing of administration</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal febrile morbidity/fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.42, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.39, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.15, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5593</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.32, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8428</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.34, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.11, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Maternal endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4965</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.26, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.36, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.18, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal serious infectious complications <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.12, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3893</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.19, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.04, 3.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal urinary tract infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.50, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.43, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.18, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.96 [0.12, 71.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.44 [0.88, 6.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.17 [0.24, 19.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal days in hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Before cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.59, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 After cord clamping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.55, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Timing not defined</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.82 [‐1.34, ‐0.31]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antibiotics versus no antibiotics ‐ subgroup by timing of administration</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007482.pub3/references#CD007482-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007482.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007482-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007482-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007482-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007482-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007482-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD007482-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD007482-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007482\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007482\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007482\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007482\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007482\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007482.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007482.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007482.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007482.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007482.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714093660"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007482.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714093664"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007482.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d662d0fd9937d',t:'MTc0MDcxNDA5NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 